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Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy 
(MRS) are both important non-invasive tools in the field of biomedical research. 
The most common application is in  the brain: however, adaptation of these MR 
techniques make them applicable to many other tissues and organs. One of these 
fields is musculoskeletal imaging where many different techniques are available to 
map various characteristics of healthy and diseased skeletal muscle. An important 
development in this field is the switch from qualitative visual assessment to 
quantitative measurements of tissue properties, which can be used to map the 
course of a disease, to evaluate potential therapeutic effects, and to investigate the 
effects of potential confounding factors on interpretation. One of the most common 
applications is in muscular dystrophies. 
1.1 Skeletal muscle
Skeletal muscle is a highly ordered structure surrounded by connective tissue called 
the epimysium. The epimysium encloses the whole muscle and protects it from 
friction against other muscles and bones. A muscle consists of multiple fascicles, 
each surrounded by the perimysium and containing multiple fibers, which are in turn 
enclosed by the endomysium. All these connective tissue layers are interconnected 
and play an important role in force transmission. Small blood vessels and motor 
axons cross the perimysial space to make connections with muscle fibers. An 
individual muscle fiber is filled with sarcoplasm in which the myofibrils, ribosomes 
and mitochondria are located. In the myofibril, protein filaments (myofilaments) 
are organized in repeating units called sarcomeres. A sarcomere includes actin 
and myosin, contractile proteins which are essential for the generation of a muscle 
contraction. In addition to these contractile proteins, there is a wide variety of 
structural proteins in the sarcomere such as titin, nebulin and dystrophin, whose 
function is to maintain the architecture of the sarcomere. These organized repeating 
units are surrounded by the endoplasmic reticulum (Figure. 1.1). The endoplasmic 
reticulum stores calcium ions which are released when an action potential arrives at 
the T-tubulus. The rapid release of calcium ions activates the myofilaments that work 
together to generate force. The force developed in an individual muscle cell needs to 
be transferred to the musculoskeletal system in order to facilitate movement. The 
interconnection of all the connective tissue layers ensures that force is transferred 




Figure 1. A schematic overview of skeletal muscle showing the arrangement of the various components.
1.2  Duchenne Muscular Dystrophy
Clinical phenotype 
Duchenne Muscular Dystrophy (DMD) is the most common neuromuscular disorder, 
with an incidence of 1 in 3500 newborn boys. 1   It is an X-linked disease caused by a 
mutation in the DMD gene which codes for the protein dystrophin within the muscle 
cell. 2 The disease is characterized by progressive muscle damage, weakness and 
functional impairment. In DMD patients, the first symptoms often become apparent 
between the ages of 2 and 4 years old and consist of walking abnormalities, difficulties 
in climbing stairs, rising from the floor and running. 3 Many patients show pseudo-
hypertrophy of the muscles, most notably in the calf muscles. The progressive loss 
of muscle strength results in wheelchair dependence in their early teens, after which 
upper limb function starts to decrease and frequently, scoliosis occurs. 4-6 In the late 
teens, patients develop respiratory impairments and need assisted ventilation.7,8 In 
all DMD patients the heart muscle also becomes affected with age and mainly results 
in dilated cardiomyopathy.9 Some patients suffer from learning and behavioral 
disabilities and the Intelligence Quotient (IQ) has been found to be one standard 
deviation below the general population.10-12 Although life expectancy and quality of 
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life gradually increased due to treatment with corticosteroids, assisted ventilation 
and spinal fixation for severe scoliosis, most DMD patients die in their mid-thirties 
due to cardiac and respiratory failure. 13 
Figure 2. Cross-section of a muscle biopsy of the tibialis anterior muscle of a DMD patient showing 
Muscle pathology
In muscle, dystrophin anchors the contractile apparatus to the muscle basement 
membrane via connections with the dystroglycoprotein complex.14,15 Absence of 
dystrophin results in ongoing muscle damage, but the exact mechanism of how 
16 
hallmarks are clearly visible in muscle biopsies which contain an increased variation in 




4,18 Nonetheless, exhaustion of this regeneration capacity of the muscle 
eventually results in the replacement of muscle tissue by fat and connective tissue 
which is considered to be the end stage of the disease. 19  It is not completely clear 
whether the initial increase in muscle mass through hypertrophy is to compensate 
in part for the loss of force-generating capacity or should be considered an intrinsic 
aspect of this type of muscular dystrophy. 20,21 
1.3 Quantitative MR  in  skeletal muscle. 
MR contrast
In MR the effect of two primary relaxation mechanisms on water protons is used 
to create image contrast, T1 and T2 relaxation. T1 relaxation is the mechanism 
by which the longitudinal magnetization returns to its thermal equilibrium and 
reflects the energy transfer from spins to the environment, consisting of atoms 
and macromolecules. Each of these structures has its own characteristic tumbling 
rate (motion of the spin) which depends on the size and structure of the molecule 
and is driven by the thermal energy. The T1 is shortest when the tumbling rate is 
almost equivalent to the Larmor frequency of the spin in the main magnetic field, 
both faster and slower tumbling rates are less efficient and result in longer T1’s. T2 
relaxation is the dephasing of the transverse magnetization and is determined by 
the interactions between spins in the tissue, which will lead to slight differences in 
resonance frequency. This difference in frequencies is measured by the dephasing 
of spins and generates T2 contrast. By varying of sequence parameters, such as 
echo time (TE) and repetition time (TR), different image contrasts can be generated 
based on the T1 and T2 of the tissue. 
MR in Skeletal muscle 
Skeletal muscle has a short T2 relaxation time, long T1 relaxation time and high 
diffusivity of water protons. Consequently, application of MR techniques in skeletal 
muscle is challenging, as these tissues intrinsic MR properties all act to reduce the MR 
signal in a given sequence. These intrinsic tissue characteristics can change due to 
damage and disease, and as such can be a direct reflection of the disease. However, 
these pathology-related changes, for example muscle inflammation, metabolic 
alterations, or the replacement of muscle tissue by fat, can also act as confounders in 
the MR measurement. The recent switch from qualitative to quantitative assessment 
of skeletal muscle tissue properties with MR stresses the importance of high quality 
data, and the need to correct for such confounding effects. Acquisition of high 
quality data can naturally be achieved by using long measurement times. However, 
these long measurement times are generally experienced as uncomfortable and 
increase the risk of, for example, movement during the measurements which can 
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directly affect data-quality. In addition,  a wide variety of MR-related parameters 
need to be assessed in order to be able to correct for any potential confounding 
factors, which is a time-consuming process. For newly-introduced techniques, it 
is generally unclear if there are any confounding factors and what, in the end, the 
effect might be on the measurements: the existence of confounding factors needs 
to be  investigated to determine their effects on the final quantitative information 
from the scans. 
Magnetic Resonance Imaging and Spectroscopy in DMD
Quantitative MR techniques have been frequently used to assess individual 
pathophysiological processes in Duchenne Muscular Dystrophy (DMD). 22 To start 
with, the replacement of muscle tissue by fat and connective tissue has been 
studied extensively. Both quantitative and semi-quantitative techniques showed 
variations in the extent and the rate of disease progression between different leg 
muscles.20,23-29 In addition, quantitative techniques also showed that muscle fat 
fraction correlated well with disease progression and functional measures. Another 
MR measure which is often used in DMD, and is thought to reflect the inflammation 
component of the disease, is water T2 relaxation times. Water T2 values have shown 
to be elevated compared to healthy controls and to decrease with age and disease 
progression in DMD. 30-32 Moreover, water T2 values have been shown to decrease 
towards more healthy values after three months of corticosteroid treatment. 
33 Consequently, both  muscle fat fraction and water T2 values are frequently 
used as outcome measures in therapeutic evaluations (https://clinicaltrials.gov/
search?cond=DMD+Therapy+MRI). Finally, changes in energy metabolism can 
be detected with phosphorous spectroscopy (31P MRS). Elevated phosphodiesters 
levels, reduced phosphocreatine levels and a more alkaline intracellular tissue pH 
have been detected in DMD.34-37 In addition, changes in energy metabolites have 
been found in relation to age, disease progression and functional measures. 37-41 So 
far the main focus of the field has been on quantifying individual pathophysiological 
processes in relation with function, disease progression, therapy and on detecting 
differences between individual muscles. However, to date, very little is known about 
how these individual pathophysiological processes relate to each other as well as to 
differences within an individual muscle.
Challenges in scanning of (young) children
Imaging studies in young pediatric populations remain relatively scarce due to 
the practical and technical challenges imposed during scanning of non-sedated 
subjects. Those challenges include motivation, alertness and cooperation of the 
child, but also anxiety caused by loud noise and the confined space of an MR scanner. 
13
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1Various strategies have been proposed to improve a child’s compliance during scanning without using sedation. 42 In the studies described in this thesis we used 
a mock scanner combined with a clear explanation of the procedure in appropriate 
terminology and a flexible approach based on the needs of the participant to 
improve the compliance. In addition to this, wearing their own metal-free clothing, 
bringing their own stuffed animal, and listening to their own music can result in a 
more familiar situation which improves the state of the patient. The presence of 
a parent, sibling or friend of the family in the MRI room can also put the child at 
ease. Alternatively, the presence of parents, sibling or guardians can also negatively 
influence the child which complicates the scanning procedure. During scanning, it is 
highly important to be aware of the state of the participant, as children sometimes 
do not express their feelings. Boredom, anxiety, discomfort and frustrations need 
to be detected and dealt with properly to ensure data quality: for example by using 
compliments, positive feedback and reminders about the essential things during 
scanning. 
A number of MRI and MRS techniques applied in skeletal muscle will be discussed in 
more detail in the following section, as they are an essential part of this thesis. The 
discussion will focus on the basic characteristics of the method, confounders, data 
quality and factors which need to be considered during quantification. 
1.4 Water fat imaging and 1H MRS to assess muscle fat infiltration
One of the most common pathophysiological changes in damaged and diseased 
skeletal muscle is the progressive replacement of muscle tissue by fat. 43,44 45,46 There 
are two main approaches used to assess muscle fat infiltration in skeletal muscle.  
1H MRS
The first approach is single voxel (SV) proton spectroscopy (1H MRS) which is based 
on the difference in resonance frequency between water and fat protons. This 
technique measures the net equilibrium precessing magnetization of a desired 
nucleus, in this case protons, in a specific volume of interest, and depicts it as a 
function of their resonance frequency. This results in a frequency spectrum in which 
the resonances can be assigned to known functional groups, such as water and lipid 
(and also other macromolecules), and can be quantified. The total lipid signal in a 
typical 1H spectrum consists of a number of spectral peaks at varying resonances 
and with varying amplitudes, while the water protons resonate at a single frequency 
(Figure 3). The lipid signal measured at clinical field strengths is represented by six 
fat peaks. It is dominated by lipid frequencies resonating between 0.5-2.75 ppm, and 
is often referred to as the aliphatic fat peak.47 The lipid signal resonating at 5.3 ppm, 
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very close to the water signal, is called the olefinic fat peak. The apparent fat fraction 
can be derived from the integrated area of all the lipid signals and the water signal. 
One of the disadvantages of this method is that it only reflects a specific volume 
of interest. Therefore, it is less representative in heterogeneous tissue types, or in 
situations where one needs information from multiple muscles at once. 
Figure 3. A proton MR spectrum at 3T. Water signal appears as a single peak at 4.7ppm (orange), 
the dominant methylene peak at 1.3 ppm (5) and the methyl peak at 0.9 ppm (6). 
Water Fat Imaging
The second approach is a quantitative imaging technique called Dixon, first 
introduced in 1984.48 This method also allows separation of water and fat tissue 
based on the difference between the precessional frequencies of protons in water 
and fat. The conventional 2-point-DIXON method relies on the acquisition of two 
images with a gradient echo sequence, one in which water and fat are in-phase 
(IP) and one in which water and fat are out-of-phase (OP). Adding and subtracting 
these two images generates water and fat images, which combined can be used to 
quantitatively calculate an apparent fat fraction (Figure 4). One of the drawbacks 
of this method is that the reliability of the fat and water separation, by adding and 
subtracting images, is highly dependent on the magnetic field (B0) inhomogeneities. 
This conventional method has been extended to the so-called 3-point-Dixon method 
which contains an additional third echo resulting in the ability to account for phase 
differences introduced by minor field inhomogeneities.49 However, the situation 
described above is oversimplified, since it assumes a single resonance frequency 
15
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1for water and fat, whereas the fat signal consists of a number of spectral peaks all contributing differently to the total fat signal. 47,50 The underlying algorithm of the 
3-point Dixon can be modified to account for the individual fat spectral peaks.51 52 
Figure 4. Axial in-phase (IP) and out-of-phase (OP) images and their reconstructed water and fat map 
of a right lower leg of a DMD patient. Note that the bright signal in the water images originates from 
muscle while in the fat images the bright signal is located in the subcutaneous fat. 
The gradient echo 3-point Dixon method is used for all studies quantitatively 
assessing fat fraction in this thesis. A few factors will be discussed that need to be 
considered during the Dixon quantification process. First, the T1 relaxation effect 
which could result in an overestimation of the fat fraction, due to a shorter T1 of 
fat, as this difference in T1 relaxation time between water and fat protons results in 
quicker relaxation of the fat signal within a short sequence TR.53,54 For the data to be 
truly quantitative, this effect has to be minimized by using appropriate sequence 
parameters, for instance by using an optimized combination of a specific flip angle 
and TR. Secondly, the number of peaks taken into account in the reconstruction 
algorithm has a pronounced effect on the accuracy of the assessed fat fraction. 
Single peak models, solely aimed at the dominant methylene fat peak, responsible 
for 70% of the total fat signal, have shown to underestimate the total fat fraction 
compared to multi-peak models.55,56 Another confounder is the T2* relaxation 
effect, which originates from signal relaxation between echoes due to minor field 
inhomogeneities. 57 Despite the fact that this effect is small in tissues with no 
significant iron concentrations, this could result in an overestimation of fat fractions 
in low fat ranges. These effects can be accounted for in post-processing, where a 




1.5 (Water) T2 relaxation time to assess inflammation and 
edema-like processes
The T2 relaxation time is a tissue specific constant which reflects the interaction 
of a group of proton spins dephasing with respect to each other. The T2 relaxation 
behavior should be mono-exponential in case of a single component, such as 
protons in water that reside in the same compartment. However, the transverse 
relaxation behavior of most biological tissues, including muscle, has shown to be 
multi-exponential. 59 Changes in T2 are often associated with pathology, for example 
elevated water T2 values in skeletal muscle are thought to reflect processes such 
as inflammation or edema. Elevated water T2 values are also found after exercise. 
By contrast, reduced water T2 values in skeletal muscle have been associated with 
fibrosis. 60,61 
1H MRS to assess water T2
There are two main techniques used to quantitatively assess water T2 relaxation 
time in skeletal muscle. First of all, SV 1H MRS which measures the T2 relaxation 
behavior of any tissue component independently of others, in this case water, and is 
in-vivo generally reflected by a mono-exponential fit. This MRS method with mono-
exponential fit is assumed to be the gold standard and has been shown to be a robust 
and quantitative measure to assess water T2 within a specific region of interest in 
both healthy and diseased tissue. 62-64 However, as mentioned before, this method 
can only generate information from one specific region of interest and is therefore 
not representative in heterogeneous tissue types.
Quantitative T2 imaging to assess water T2
The second approach is a Multi Spin Echo (MSE) acquisition, which is a quantitative 
imaging method that can cover a large region of interest (ROI) and contains 
information from multiple muscles at once. This approach is based on a simple Carr-
Purcell-Meiboom-Gill sequence, where a 90-degree pulse is followed by a series of 
180-degree pulses at multiple echo times, which allows assessment of the relaxation 
behavior of protons bound to various tissue components. The T2 relaxation times 
of these tissue components can differ. For example, the T2 relaxation time of fat 
protons is relatively long (> 90ms) compared to that of water (25-30ms). These 
two components together, when originating from the same tissue compartment, 
create a bi-exponential signal. However, the relaxation behavior of these two tissue 
components can still be approximated by a mono-exponential fit. 65,66 This combined 
relaxation behavior of protons in water and fat is then referred to as global T2 values. 
In healthy skeletal muscle, global T2 values and water T2 values are almost equivalent, 
due to the only very minor contributions of the protons in fat. However, one of 
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1the most common pathophysiological changes in damaged and diseased muscle is the replacement of muscle tissue by fat. Consequently, an increase in muscle 
fat fraction will result in more slowly decaying signal that results in measuring a 
prolonged T2 relaxation time. This increase in the T2 relaxation time is proportional 
to the fat fraction, and may falsely indicate muscle inflammation. Hence, additional 
approaches are necessary to separate the contribution of the fat and water protons 
to the total T2 signal in order to derive the true water T2. This is particularly important 
in situations where a significant amount of fat is present. 
Figure 5.
patient showing the 1st echo (TE: 8ms); the reconstructed T2
There are multiple approaches to separate the contribution of the water and fat 
protons. Two of these approaches are often used in skeletal muscle T2 measurements 
and will be discussed in more detail. The first one is based on an addition to 
the acquisition scheme, a Spectrally Adiabatic Inversion Recovery (SPAIR) fat 
suppression pulse aimed at the main methylene and methyl fat peak.67 (Figure 2) 
This resonance-specific method is based on the idea that when fully suppressing the 
main fat peak one can solely acquire the water signal. This method then assumes 
mono-exponential behavior of the water protons. It is important to note that this 
approach is highly sensitive to B0 inhomogeneities as it has a resonance-specific 
fat suppression pulse. As a result, one should be extremely careful when using 
this method for quantification purposes because the fat suppression pulse can be 
inconsistent between examinations. In addition, previous work also showed that the 
significant influence of the fat signal on the measurement increased in the higher 
fat ranges.68 This suggests that this measurement does not purely reflect the water 
signal. The second approach separates the multi-exponential behavior of the T2 
signal in post-processing by either a tri-exponential or an Extended Phase Graph 
(EPG) based fit. 43,69,70 A minimum number of echoes is essential to obtain a proper fit 
of the signal and advanced post-processing is needed to obtain quantitative values. 
18
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The MSE in combination with the advanced tri-exponential fitting method has been 
used in all studies assessing water T2 in this thesis (Figure 5). 
There are a few factors which need to be considered during quantification. First of 
all, the MSE method is more sensitive to B1
+ field inhomogeneities compared to the 
MRS approach due to the larger field of view (FOV). The effect of these potential 
B1
+ inhomogeneities should be taken into account when using the MSE approach. 
The EPG based fit incorporated these B1
+ field fluctuations in the model, but that 
is not the case for the advanced tri-exponential signal fit. Consequently, in that 
case additional approaches, for example mapping of the B1
+ field, are necessary to 
correct for these B1
+ inhomogeneities (see the next section). Secondly, relatively 
high water T2 values have been found with the advanced fit MSE approach compared 
to the MRS approach.71 This difference in T2 values has been attributed to imperfect 
slice profiles in the MSE approach caused by the absence of adequate RF-spoiling 
schemes on most clinical systems.66,71 These RF imperfections result in stimulated 
echoes (additional signal) which can result in measuring elevated water T2 values. 
This needs to be considered when comparing water T2 values between studies. 
1.6 B1
+ field mapping approaches
There are two approaches often used to map the B1
+ field: the double angle method 
(DAM) and the double TR method for actual flip angle imaging (AFI). 72,73 The double 
the true flip angle can be derived from those two images by calculation. The double 
TR method uses two varying repetition times to derive the actual Flip Angle. This 
B1
+ field information can be used as prior knowledge or as cut-off values in post-
processing to ensure data-quality in any B1
+ field sensitive acquisition. To date, this 
is still a relatively time-consuming process without any direct diagnostic value, 
so acceleration of this process is highly desirable. Recently, a relatively new fast 
Dual Refocusing Echo Acquisition Mode (DREAM) B1
+ mapping technique has been 
proposed which allows acceleration by two orders of a magnitude. This method 
seems very promising but needs further evaluation in clinical applications.74,75 
1.7 Diffusion Tensor Imaging to assess muscle structure
Diffusion Tensor Imaging (DTI) is a quantitative imaging technique aimed at probing 
water diffusion, the random microscopic movement of water, which in skeletal 
muscle is hindered by structures such as mitochondria, the sarcoplasmic reticulum, 
macromolecules and the cell membrane. This hindered diffusion can be described 
by a parameter called the apparent diffusion coefficient (ADC), which is an indirect 
reflection of the muscle microstructure. Introducing diffusion weighting into the 
19
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1sequence attenuates the signal more from tissues which allow unrestricted diffusion of water, thus producing higher relative signals from tissues in which the movement 
is restricted. By using two or more diffusion-weighted sequences and comparing 
the relative tissue signal intensities it is possible to calculate ADC maps, showing 
diffusive properties of tissue in different regions of interest. 
Figure 6. 
spacing, and TM is the mixing time. 
There are two main MR techniques used to map the diffusion properties of water in 
skeletal muscle. The first is the spin-echo echo-planar imaging sequence (SE-EPI), 
a fast, movement-robust and intrinsically T2-weighted method, most commonly 
used with Stejskal-Tanner diffusion encoding (Figure 6 (top)).76 The main challenge 
for this method is to achieve sufficient diffusion weighting within reasonable echo 
times since muscle tissue has a relatively short T2 relaxation time. The amount of 
diffusion weighting is directly related to the b-value, a higher b-value generates 
more diffusion weighting. A given b-value is dependent on the gradient amplitude 
(g), gradient strength, the gyromagnetic ratio of the nucleus and the gradient 
two ways to increase diffusion weighting: higher gradient strength (g) or longer 
gradient duration ( ). (Figure 6) However, the maximal gradient strength on most 
clinical scanners is limited due to subject safety limitations. In order to reach 
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higher b-values one has to increase the gradient spacing or duration. Both of these 
adjustments result in longer TE’s which has a high impact on Signal to Noise Ratio 
(SNR) due to the muscle tissue’s short T2. An alternative approach is the Stimulated 
Echo (STE) sequence which avoids the T2 decay by storing the magnetization in the 
longitudinal plane, which causes the signal to be attenuated by T1 decay, and T1>T2 
for all tissues.77 The 180-degree refocusing pulse is replaced by two 90-degree radio 
frequency pulses which are separated by the mixing time (TM). (Figure 6 (bottom)) 
This results in a direct loss of approximately 50% of the signal but allows much 
longer mixing times within the same echo time. These longer mixing times result in 
the ability to probe longer distances which can be advantageous in larger structures.
A minimum of six non-collinear diffusion directions are necessary in order to quantify 
the directionality of the diffusion within one individual voxel by calculating the 
diffusion tensor. The tensor can be diagonalized to obtain three eigenvectors (v1, v2, 
v3 1 2 3). These eigenvalues are commonly 
1) represents the 
direction in which diffusion is dominant. As such, in skeletal muscle this represents 
diffusion along the fiber length; the first eigenvector defines the fiber orientation 
2) points 
along a direction that is orthogonal to the first eigenvector (v1). The third eigenvalue 
3) is orthogonal to both the first eigenvector (v1) and the second eigenvector (v2). 
1 2 3) are equal, whereas when it is 
1 2 3 
1 2 3). Radial diffusivity is the average of the second and third eigenvalue 
2 3) and represents the average diffusion orthogonal to the dominant 
direction. The radial diffusivity is thought to be most sensitive to changes in muscle 
due to the elongated shape of the fibers. From these three eigenvalues two other 
measures can be computed. The mean diffusivity (MD) is the average of the three 
eigenvalues and reflects the average diffusion in tissue. The fractional anisotropy 
(FA) is a dimensionless scalar index which varies between zero (isotropic) and one 
(anisotropic) and reflects the amount of directionality in the tissue. 78,79 These five 
measures are generally used to describe tissue microstructure and have been shown 
to change with respect to age, gender, exercise, injury and disease; and to vary 
between individual muscles.80-94 95
High quality data is essential to obtain reliable estimates of these DTI-based 
parameters. However, reaching sufficient SNR is challenging in skeletal muscle due to 
the tissue’s short T2, long T1 and relatively high diffusivity of water. Simulation studies 
have evaluated the effect of SNR on the DTI parameter estimation. They predicted 
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1an underestimation of MD and the three eigenvalues, and an overestimation of FA in low SNR data.80,89 In addition, changes in T2, often associated with muscle damage 
may indirectly influence the DTI parameter estimation in the SE-EPI sequence due 
to associated changes in SNR. Finally, simulation studies showed that the presence 
of fat signal can result in an inaccurate DTI parameter estimation due to the fact 
that fat has a diffusion coefficient two orders of magnitude lower than water. 96 
This is particularly important in applications where there is a significant amount 
of fat tissue present in the region of interest, such as in muscular dystrophies. 
Multiple approaches have been investigated in order to suppress the effect of the 
fat signal.97 One of the methods which generates good overall suppression of the 
spectrum is a combination of a SPAIR pulse and a Slice Selective Gradient Reversal 
(SSGR) technique both aimed at the main methylene and methyl fat peaks, together 
with a second spectral suppression pulse aimed at the olefinic fat peak. (Figure 3) 
Essential to keep in mind is that this method needs adjustments on the acquisition 
side and is highly sensitive to B0 field inhomogeneities.
96 Recently, a relatively new 
method has been introduced which uses an arbitrary chemical-shift angle dual echo 
Dixon method to perform image reconstruction of diffusion-weighted images with 
suppression of the entire fat spectrum. 98 The SE-EPI sequence in combination with 
the three-component fat saturation technique was used for all DTI measurements 
in this thesis.  
1.8 Phosphorous Magnetic Resonance Spectroscopy (31P MRS) 
to assess energy metabolism
31P MRS is a quantitative technique used to assess energy metabolism in skeletal 
muscle either in rest or in non-steady state conditions. As mentioned previously, 
this technique is based on the concept that nuclei of the same type, in this case 
31P, resonate at slightly different frequencies in different chemical environments, 
due to minor differences in shielding exerted by the electron cloud.  This gives rise 
to a spectrum of frequencies which can be assigned to known metabolites. A 31P 
spectrum of skeletal muscle contains a variety of peaks from (muscle) metabolites 
including Inorganic Phosphate (Pi), Phosphocreatine (PCr), Phosphodiesters (PDE), 
Phosphomonoesters (PME) and Adenine-Tri-Phosphate (ATP). An example of a 
spectrum obtained in skeletal muscle at a 7T MR system is shown in figure 7. 
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Figure. 1.7: Typical 31P spectra of the Soleus muscle of a healthy (adult) control subject. 
Ratios between these phosphorous compounds can reflect for instance muscle 
metabolic reserve and oxidative phosphorylation capacity. 99,100 In addition, the shift 
in resonance between the Pi and PCr peak can be used to calculate the intracellular 
tissue pH. These ratios and intracellular tissue pH slightly vary between the individual 
muscles at rest.101,102
MRS measurements are commonly based on a simple free induction decay (FID) 
readout without gradients during the spatial encoding which results in signal without 
any spatial information. There are three ways commonly used to spatially localize 
MRS data: surface coil localization, single voxel localization and spectroscopic 
imaging. Surface coil localization is most commonly used for 31P MRS measurements 
in skeletal muscle and is based on measuring one single FID for all the signal picked 
up by the coil. This method is very fast and has short TE’s which is advantageous 
since 31P compounds have relatively short T2 relaxation times. The sensitivity of 
this method is highly influenced by the shape and size of the coil, and the signal 
is weighted towards tissue located more closely to the surface. Consequently, the 
signal obtained with this method is a mixture of multiple tissue types and has a 
high inter-subject variability which needs to be considered when interpreting the 
results. Secondly, there are single-voxel localization approaches which generate 
rapid information from a well-defined small ROI with a relatively homogeneous 
magnetic field. This method uses a combination of three slice-selective RF pulses 
in orthogonal planes through which a signal arises at the intersection of these three 
planes. This localization method is highly sensitive to the chemical shift displacement 
artefact (CSDA), especially at high magnetic fields, and works less efficiently in 
heterogeneous tissue types. In addition, the relatively long TE’s, pertinent to this 
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1method, in combination with the relatively short T2 times of the various phosphorous compounds result in a lot of signal loss. 103  Lastly, there are Chemical Shift Imaging (CSI) 
magnets. The acquisition of this technique is based on a simple FID readout, spatially 
localized in 1D, 2D or 3D by a combination of a single excitation pulse and phase 
encoding steps. This technique is very well suited for heterogeneous tissue types, is 
31P imaging. This imaging technique can be used to map PCr with high temporal and 
spatial resolution compared to spectroscopy approaches. This is advantageous in 
exercise settings and heterogeneous tissue types. However, this method is only aimed 
at one or two resonances, which limits application possibilities.104 The 2D chemical 
shift imaging method was used for all 31P MRS studies in this thesis.
There are a few general points which need to be considered when quantitatively 
assessing energy metabolism with 31P MRS. First, one of the most essential points 
for MRS in general is adequate shimming of the B0 field which has a direct relation 
to SNR and linewidth. Generally, a drop in SNR and an increase in linewidth result in 
a less accurate estimation of the area under curve and thus of the metabolite ratios. 
These effects can be minimized by enforcing strict acceptance criteria that limit 
spectra to minimum SNR and maximum linewidths to ensure proper quantification 
and comparisons of energy metabolism among individuals. Second, the saturation 
effect due to variation in T1 relaxation of the various phosphorus compounds needs 
to be considered. In practice, the T1 relaxation times of 
31P metabolites are too long 
to allow complete saturation before the next excitation pulse. These relaxation 
effects can be accounted for in post-processing using literature values, or by 
measuring the full relaxation of the various compounds. They can also be reduced 
during acquisition by using the Ernst angle for excitation. 103 Last, all individual 
quantification method assumes that muscle ATP is constant or at least is preserved 
as long as possible in skeletal muscle. However, this might not always be the case. 
1.9 Objectives of this thesis
The overall aim of this thesis was to combine various quantitative MR measurements 
and to compare these between DMD patients and healthy age-matched controls, 
both on a cross-sectional and longitudinal level, to generate a better understanding 
of the underlying pathophysiology and ideally to explore the value of these MR 
outcome parameters to monitor muscle tissue changes in a clinical setting.  In order 
to achieve this aim we: 
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Chapter 1
1. measured muscle fat infiltration, inflammation, fiber architecture and 
energy metabolism in healthy and diseased muscle on a cross-sectional and 
longitudinal level.
2. combined these MR techniques to assess the effect of spatial localization, 
data quality and confounding factors on the quantification process of MR 
outcome measures.
3. combined these MR parameters to have a better understanding of the 
underlying pathophysiology of DMD.
Thesis Outline
This thesis is divided into two main parts, preceded by an introduction and followed 
by a general discussion. The first part focuses on the effect of methodological 
factors such as data-quality, accurate spatial localization and confounding factors on 
quantification of MR outcome measures in skeletal muscle applications. In chapter 2, 
the effect of %fat, SNR and T2 changes on the DTI measurements in skeletal muscle 
of DMD patients and healthy controls has been evaluated using multi-parametric 
MRI. In chapter 3, the accuracy of spatial localization is stressed using 3-point-dixon 
imaging for fat quantification along the proximodistal muscle axis in DMD patients. 
In chapter 5, the effect of data quality, accuracy and reproducibility of quantifying 
PDE-levels with 31P MRS was assessed in healthy control subjects. The second part 
of this thesis is focused on the importance of combining various imaging techniques 
in order to have a better understanding of the underlying pathophysiology in DMD 
and to explore the value of MR measures to monitor muscle tissue changes. Chapter 
3 assessed variations in muscle degeneration within individual leg muscles of DMD 
patients. Chapter 4 presents combined qMRI and spatially-resolved (2D-CSI) 31P 
MRS data of the leg muscles in DMD patients to determine metabolic changes and 
inflammation in muscles with and without fat infiltration, to assess if metabolic 
changes and inflammation vary in different stages of the disease process. Chapter 
5 presents longitudinal and spatially resolved 31P MRS and qMRI data of lower leg 
muscles that represent varying levels of muscle deterioration, aimed to assess 
whether phosphodiester (PDE)-levels detected by 31P MRS could be a marker 
for muscle tissue changes. In addition, the course of the other metabolic indices 
over two-year time-period was assessed. Finally, chapter 6 aims to bridge the gap 
between the research field and clinical practice by accelerating of sequences, as it 
focuses on the implementation of a fast B1
+ shimming technique to improve image 
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Diffusion tensor imaging (DTI) is a popular method to assess differences in fiber 
organization in diseased and healthy muscle tissue. Previous work has shown that muscle 
DTI measurements depend on signal-to-noise ratio (SNR), %fat, and tissue T2. The goal 
of this study was to evaluate the potential biasing effects of these factors on skeletal 
muscle DTI data in patients with Duchenne Muscular Dystrophy (DMD). MR images were 
obtained of the right lower leg of 21 DMD patients and 12 healthy controls on a Philips 3T 
system. DTI measurements were combined with quantitative in-vivo measures of mean 
water T2, %fat and SNR to evaluate their effect on DTI parameter estimation. All outcome 
measures were determined within ROIs drawn for six lower leg muscles. Between group 
analysis, using all ROIs, revealed a significantly elevated FA in the GCL, SOL and PER 
3 (p<0.05) in the TA 
muscle of DMD patients. In-vivo evaluation of the individual confounders showed 
behaviour in line with predictions from previous simulation work. To account for these 
confounders, subsequent analysis used only ROIs with SNR greater than 20. With this 
criterion we found significantly greater MD in the TA muscle of DMD patient (p<0.009) 
3 in the TA and GCL muscles (p<0.001) of DMD patients, but no differences in FA. As 
3, these 
between-group differences are likely due to pathophysiology. However, the increased 
FA, observed when using all ROIs, likely reflects the effect of low SNR and %fat on the 
DTI parameter estimation. These findings suggest that measuring mean water T2, %fat 
and SNR is essential to ascribe changes in DTI measures to intrinsic diffusion changes or 
to confounding influences.
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2
Introduction
Spin-echo-based diffusion tensor imaging (DTI) is an intrinsically T2-weighted 
method to measure the apparent diffusion of water molecules in tissue. Water 
diffusion can be hindered by structures such as mitochondria, sarcoplasmic 
reticulum, macromolecules and the cell membrane. 1 DTI is commonly used as a non-
invasive and quantitative method to assess fiber organization in healthy, diseased 
and damaged skeletal muscle. 2-8 Changes in DTI parameters have been observed 
with respect to age, gender, injury, disease and exercise, as well as between 
individual muscles, showing the potential of DTI as a measure for overall muscle 
quality. 9-15 DTI has also been used to assess changes in fiber type distributions, to 
monitor muscle recovery after marathon running, and to discriminate between 
different phases of the recovery after artery ligation. 16-19 As DTI is a quantitative 
technique, high quality data are necessary to obtain reliable estimates of DTI based 
parameters. Even in healthy muscle tissue it is challenging to achieve high signal-to-
noise-ratio (SNR) due to the tissue’s short T2, long T1, and a relatively high diffusivity 
of water. Recently, several simulation studies have shown that the reliability of 
estimating DTI parameters is substantially affected by the SNR, water T2 value, 
and percentage fat composition (%fat). 20-22  These simulation studies predicted 
that low SNR data result in an overestimation of fractional anisotropy (FA) and 
1 2 3) and mean diffusivity (MD). 
20, 22 Increases in T2, often associated with muscle damage, may indirectly affect 
the diffusion parameters due to the associated increase in SNR. 20, 22 In addition, 
the increases in fat % associated with age and pathology may alter the diffusion 
parameters due to increased partial volume effects. 20, 22 DMD is an X-linked disease 
caused by a mutation in the dystrophin gene, and is characterized by progressive 
muscle weakness and muscle damage. 23 In many muscular dystrophies, muscles 
show structural changes such as fat infiltration and fibrosis that increase with age, as 
well as oedema and/or inflammatory processes which increase the mean water T2. As 
a result, true differences in DTI measurements in this population may be obscured by 
MR confounders such as increased fat fraction and increased T2. 
24-26 The majority of 
previous skeletal muscle DTI studies have focused on its properties as a non-invasive 
and quantitative method to assess differences in microstructural organization and 
on performing fiber tractography. However, the potential role that confounders 
such as SNR, %fat and water T2 values could have on the detected differences in DTI 
parameters in healthy and diseased muscle has not been addressed experimentally 
in patients with a muscle disease. The overall purpose of this study was to acquire 
skeletal muscle DTI measurements in patients with DMD and healthy controls, 
combined with measurements to assess mean water T2, %fat and SNR for an in–vivo 
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evaluation of their effect on the DTI measurements. Furthermore, DTI was used as a 
non-invasive and quantitative method to assess changes in DTI parameters between 
these groups. Finally, the feasibility of ascribing these changes to pathology or 
confounding effects using multi-parametric MRI was assessed. As such we obtained 
data in a group of DMD patients and age-matched healthy controls and looked at 
the differences in DTI parameters between groups. 
Methods
Study population
Twenty-one DMD patients (9.5± 3.1 yrs; range, 5-16 yrs) and 12 age-matched healthy 
controls (9.7± 2.9 yrs, range: 5-14 yrs) participated in the study. The DMD patients 
were recruited from the Dutch Dystrophinopathy Database, while the controls were 
recruited from local schools. The diagnosis DMD was confirmed by a mutation in 
the DMD gene and lack of dystrophin expression in the muscle biopsy. Of the 21 
DMD patients, 8 were wheelchair bound, 13 were fully ambulant and all boys used 
corticosteroids. The study was approved by the local medical ethics committee. All 
participants or their legal representatives signed informed consent. 
MR examination
MR datasets of the right lower leg were acquired on a 3T MR scanner (Ingenia, 
Philips, Best, Netherlands) with a 16-element anterior body receive coil. Patients 
were positioned in a feet-first supine position in the scanner. The total duration of 
the scan was 25 minutes and contained:
(i) a SE-EPI DTI sequence to obtain DTI parameters (TR/TE 2990/49 ms; 
number of signal averages (NSA) 6; number of gradient directions 
16; b-value 0,450 s/mm2; voxel size 2x2x6 mm; 12 contiguous slices; 
half scan 0.7; SENSE factor in RL direction; spectrally adiabatic 
inversion recovery (SPAIR) and slice-selection gradient reversal (SSGR) 
fat suppression on the aliphatic fat peak with spectrally selective 
suppression of the olefinic fat peak; 21
(ii) SE-EPI without diffusion weighting to determine the SNR (TR/
TE 3020/49 ms; NSA 6; b-value 0 s/mm2; voxel size 2x2x6 mm; 12 
contiguous slices; 10 dynamics, SPAIR and SSGR fat suppression on the 
aliphatic fat and selective suppression of the olefinic fat peak) 21;
(iii) TSE T1-weighted images for anatomical reference (TR/TE 630/30ms; 
voxel size 1.5x1.5x6 mm; no gap, 12 slices), 
(iv) Three point Dixon images to determine the amount of fat infiltration 
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mm;  slice gap 5 mm; 23 slices) 
(v) Multi turbo spin echo sequence to measure the water T2 relaxation 
size 1.4x1.8x10 mm; slice gap 20 mm;; 5 slices, no fat suppression). 
Data-analysis
DTI-analysis was performed using a custom-built toolbox in Mathematica. 5, 27 
Data were de-noised, registered and corrected for eddy currents before the tensor 
1 2 3), mean diffusivity 
(MD) and the fractional anisotropy (FA). A Weighted-Linear-Least-Squares (WLLS) 
method was used for tensor calculation and MD and FA were determined with 
standard equations using these eigenvalues. A separate SE-EPI sequence with 10 
dynamics was used to assess the SNR, which was defined as the mean signal over 
the 10 dynamics divided by the standard deviation over the same 10 dynamics. The 
SNR was determined per pixel and presented as a mean of all pixels within a region 
of interest (ROI), as described below. The determination of the water T2-relaxation 
times used a tri-exponential fitting routine written in MATLAB based on a previously 
described method. 28 Quantitative fat fractions were calculated as signal intensity 
(SI) fat/ (SI fat+ SI water))*100 from the 3-point Dixon images. Fat and water 
images were generated using a multi-peak model based on a six fat peak spectrum. 
Values were not corrected for T2* relaxation effects. Even though the relaxation 
between the echoes is small in tissues with no significant iron concentrations, this 
could have resulted in a small overestimation of fat fractions in the low fat ranges. 
29 Subsequently, the sequence was optimized with respect to TR and flip angle 
to minimize T1 relaxation effects. ROIs were manually drawn for the 3P-Dixon, 
MSE and the T1-weighted sequence, using Medical Image Processing, Analysis 
and Visualization (MIPAV) software (http://mipav.cit.nih.gov) for  six individual 
lower leg muscles: the lateral head of the gastrocnemius (GL), medial head of the 
gastrocnemius (GM), soleus (SOL), tibialis anterior (TA), peronei (PER) and the 
tibialis posterior (TP) muscles (Figure 1f). Boundaries of the ROIs were identified 
to always fall within a muscle in order to avoid contamination of subcutaneous fat 
and fatty septa between muscles.  The ROIs from the T1-weighted images were used 
for anatomical reference in the DTI and SNR assessments. All outcome measures 
are reported as a mean value of all pixels within a ROI over multiple slices. Because 
of sequence-specific differences in slice thickness, the number of slices used in 
the analysis varied between sequences. However, all sequences covered the same 




Simulations were performed according to Froeling et al. and Damon et al.. For the 
simulations the parameters were set identical to the MRI experiments (TE = 49 ms, 
TR = 2990 ms, 16 gradient directions and b = 450 s/mm2). The fat compartment was 
simulated using T2 = 80/550 ms with a ratio of 2:1, T1 = 300 ms, proton density  =  0.1 
and MD = 0.6 mm2/2 and FA=0. For the muscle compartment T2 = 37 ms (the mean of 
all muscles), T1 = 1200 ms and  =  0.8 were used. Two simulation experiments were 
performed:  simulation 1 - diffusion parameters as a function of SNR, simulation 2 – 
diffusion parameters as a function of the fat fraction. The muscle diffusion properties 
were set to values estimated from the normal distribution given by all muscles of 
healthy subjects with an SNR > 25 and from all muscles of Duchene patients with a 
fat fraction < 10%, for simulation 1 and 2 respectively. The fat fractions and the SNR 
was also estimated form the same subsets for each simulation. For each SNR value, 
ranging from 1 to 55 with steps of 2, and for each fat fraction, ranging from 0 to 
60 % with steps of 2 %, 5000 virtual subjects were simulated by generating a noisy 
diffusion signal using randomly selected values using the previously determined 
normal distributions of the diffusion properties, SNR and fat fraction using,
Figure 1.
weighting (b); T1-weighted image; (c) a 3-point Dixon water image; (d) the 7
th echo of a multi-spin-echo 
image (TE: 56 ms); (e) and a representation of the masks created for the 6 lower leg muscles - medial 
and lateral head of gastrocnemius (GM, GL), soleus (SOL), anterior tibialis (TA), peroneus (PER) and 
posterior tibialis (TP) ) (f). Note the complete suppression of the fat signal in (a) and (b), resulting from 
the use of the combined fat suppression method.
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        , and
where  is the noisy diffusion signal for b-value  and gradient direction ,  
is the fat fraction,  the proton density, and   the longitudinal and transvers 
magnetization,  the Rician noise signal  and  and the diffusion tensors 
for fat and muscle respectively. The simulated signal was then used to calculate the 
distribution of diffusion parameters as a function of SNR and fat. 
Statistical Analysis
The Pearson correlation coefficient was used to evaluate the correlation between 
SNR, %fat and muscle T2 value and the estimation of the individual DTI parameters. 
The evaluation of SNR involved datasets of healthy controls only. The evaluation of 
the effect of %fat on the DTI estimation involved data-sets of DMD patients with 
an SNR>20 only, so as to evaluate better the separate effects of SNR and %fat. To 
determine the effect of mean water T2 on the DTI parameters and SNR, datasets 
of both groups were evaluated individually, as DMD patients are known to have an 
elevated T2. A general linear model was used to assess differences in DTI-parameters 
and mean water T2 between patients with DMD and healthy controls. The water T2 
was included as a covariate for the DTI parameters and a Fischer least significant 
difference (LSD) model was used to correct for multiple comparisons. The between-
group analysis was performed twice, once with only datasets with an SNR>20 and 
once with all data-sets taking into account the effect of confounders. The significance 
level was set at p<0.05. All statistical analyses were performed using SPSS version 




All scans were successfully performed in DMD patients and healthy controls. 
Example multi-contrast images are illustrated in Figure 1. 
The effect of SNR
Mean SNR values averaged over all muscles were 27.9±9.8 in healthy controls (HC) 
and 20.9± 9.7 in DMD patients. The associations between DTI parameters and SNR 
are visualized in Figure 2(A-E). In the low SNR ranges, MD and the eigenvalues are 
1 (r=-0.52, 
2 (r=-0.28, p<0.049) were negatively correlated with SNR; no significant 
3. For the majority of the DTI-parameters stabilization 
of the values occurred at SNR levels above 20. Eliminating data points below this 
threshold would result in exclusion of 18% (13/72) of the total healthy control ROI’s 
and an exclusion of 47% (93/198) of the total ROIs. Twelve of the excluded HC 
ROIs belonged to two subjects. However, it should also be noted that correlations 
1 2 (r=-0.19, p=0.0175) and 
SNR remained even when ROIs with an SNR<20 were excluded. Furthermore, similar 
behaviour is visualized with the simulation experiment, describing the diffusion 
parameters as a function of SNR, in which almost all in-vivo obtained data points fall 
within one standard deviation of the simulated signal, see Figure 2(A-E). 
The effect of fat fraction
The mean %fat of all lower leg muscles was 17.4% ± 14.4% in DMD patients and 4.3% 
± 0.8% in healthy controls. Only datasets of DMD patients with an SNR above 20 were 
included in this part of the analysis, as healthy controls normally do not show fat 
also seen in  the simulation experiment, except for the FA which tends to show the 
MD (r=-0.26, p=0.04) 3 (r=-0.34, p=0.02) and no correlations were present for FA, 
1 2 in the in-vivo data. 
The effect of mean water T2 relaxation times
In all lower leg muscle, the mean water T2 was significantly greater in the DMD 
patients than in the healthy controls (p<0.001). Mean water T2 values, averaged 
over all the muscles, were 39.5±0.6ms for DMD patients and 35.1±0.5ms for healthy 
controls. Correlations between mean water T2 and the DTI parameters were assessed 
per group individually. For both groups no correlations were observed between 
the mean water T2 and the individual DTI-parameters (Figures 4A-E). Additionally, 
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Figure 2.
against the SNR. (A-E) Each dot represents an individual muscle of a healthy control subject (black) 
and seems to vary between DTI parameters. In the background of the graph, the mean (red line) 
and standard deviation (shaded area) are shown of the DTI parameters as a function of SNR derived 
from the simulation experiment using WLLS.  The grey dashed line indicates the true values used as 
input for the simulations. Clearly visible in the low SNR ranges are an overestimation of FA and an 
underestimation of MD and the eigenvalues.
Figure 3.
estimation. The individual DTI parameters are plotted against the fat fraction (%). (A-E) Each dot 
In the background of the graph,  the mean (red line) and standard deviation (shaded area) are shown 
of the DTI  parameters as a function of %fat derived from the simulation experiment using WLLS.  The 
grey dashed line indicates the true values used as input for the simulation experiment. 
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Only ROIs with a SNR>20 All ROIs
DMD Controls DMD Controls
GL N = 4 N=9 N=16 N =12
λ
1
1.95±0.08 2.01±0.04 1.93±0.07 2.13±0.08
λ
2
1.42±0.07 1.51±0.04 1.50±0.06 1.53±0.07
λ
3
1.31±0.03*(p<0.001) 1.15±0.02 1.13±0.05 1.08±0.05
MD 1.54±0.06 1.56±0.03 1.58±0.05 1.51±0.05
FA 0.25±0.02 0.26±0.01 0.33±0.02*(p=0.04) 0.25±0.02
GM N=7 N=10 N=16 N =12
λ
1
1.98±0.05 2.07±0.04 2.1±0.06 2.00±0.07
λ
2
1.50±0.04 1.46±0.04 1.49±0.03 1.46±0.04
λ
3
1.28±0.04 1.25±0.04 1.21±0.03 1.23±0.03
MD 1.56±0.05 1.61±0.04 1.60±0.04 1.57±0.04
FA 0.26±0.01 0.24±0.01 0.26±0.01 0.26±0.01
SOL N=8 N=10 N=16 N =12
λ
1
2.23±0.05 1.99±0.07 2.06±0.05 2.14±0.06
λ
2
1.70±0.05 1.59±0.05 1.69±0.04 1.60±0.05
λ
3
1.31±0.04 1.32±0.03 1.28±0.03 1.32±0.04
MD 1.72±0.05 1.64±0.04 1.65±0.04 1.73±0.05
FA 0.24±0.01 0.22±0.01 0.25±0.01*(p=0.006) 0.22±0.01
TA N=10 N=10 N=14 N =12
λ
1
2.30±0.05 2.19±0.05 2.31±0.04 2.22±0.04
λ
2
1.66±0.04 1.54±0.04 1.65±0.03 1.56±0.04
λ
3
1.33±0.03*(p<0.007) 1.17±0.03 1.31±0.03*(p=0.024) 1.2±0.03
MD 1.78±0.04*(p<0.009) 1.61±0.04 1.77±0.03*(p=0.020) 1.64±0.03
FA 0.27±0.02 0.32±0.01 0.29±0.01 0.31±0.01
PER N=5 N=9 N=14 N =12
λ
1
2.18±0.08 2.18±0.06 2.27±0.06 2.19±0.07
λ
2
1.60±0.06 1.59±0.05 1.69±0.05 1.61±0.05
λ
3
1.25±0.05 1.23±0.04 1.12±0.04 1.22±0.05
MD 1.69±0.08 1.66±0.05 1.71±0.04 1.69±0.04
FA 0.27±0.02 0.29±0.02 0.33±0.02*(p=0.049) 0.29±0.02
TP N=12 N=10 N=14 N =12
λ
1
2.18±0.05 2.18±0.06 2.31±0.04 2.25±0.05
λ
2
1.67±0.04 1.66±0.04 1.7±0.04 1.68±0.04
λ
3
1.35±0.03 1.36±0.03 1.38±0.03 1.37±0.03
MD 1.75±0.03 1.74±0.03 1.79±0.04 1.75±0.05
FA 0.23±0.01 0.28±0.02 0.26±0.01 0.25±0.01
Table 1.
1, 2, 3)) using all ROIs and using only ROIs with a SNR>20 in healthy 
controls and DMD patients of the investigated muscles (medial and lateral head of gastrocnemius 
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the correlation between mean water T2 and SNR was assessed and no significant 
correlations were found. 
Assessing differences in DTI parameters between groups
Including all ROIs:
Table 1 lists the mean diffusion values per muscle of the DMD patients and healthy 
controls using all ROIs. Between-group analysis without data selection based on the 
3 (p=0.024) 
in the TA muscle for DMD patients compared to healthy controls. Also, a significant 
increase in FA was found in the GL (p=0.04), SOL(p=0.006) and PER (p=0.049) muscles 
1 2 were observed between groups.
Including ROIs with SNR>20:
Mean and standard deviations of the DTI parameters per muscle of the DMD patients 
and healthy controls using only ROIs with SNR>20 are shown in table 1. Taking only 
ROIs with an SNR>20, a total of 47% (93/198) of the ROIs were excluded from the 
between-group analysis. Group comparison now showed a significantly increased 
3 in 
the GL (p<0.001) and TA muscle (p<0.007) for DMD patients compared to healthy 
1 2 
(Table. 1). These results are in accordance with the group analysis using all images. 
Figure 4. 2 changes on the DTI parameter estimation. The individual DTI parameters 




However, in contrast to the previous group analysis, no significant changes were 
detected for FA. Although not significantly different, some trends were observed 
towards a lower FA in the TA (p=0.059) and TP muscle (p=0.058, Fig. 5D), increased 
2 1 in the SOL muscle (p=0.084) of 
DMD patients. 
Discussion
In this study we evaluated the effect of individual confounders on the DTI-parameter 
estimation in patients with DMD and healthy controls. In line with the conclusions of 
previous simulation-based works 20-22, both SNR and %fat influenced DTI-parameter 
estimation. In contrast, the significantly elevated mean water T2 had no effect 
on the DTI parameter estimation in patients with DMD. When all data-sets were 
included in the between-group analysis, there were between-group differences 
3) than when only datasets with 
3). Because the number of statistically 
significant findings is reduced when low SNR data are eliminated, at least some 
of the between-group differences in DTI parameters are most likely to have been 
caused by confounding factors. Overall, these findings support the conclusion that 
Figure 5.
and using only ROIs with a SNR>20 of the investigated muscles in DMD patients (grey) versus healthy 
asterisk (*). Remarkable is the increased FA in some of the muscles of the DMD patients using all ROIs 
(D). (GM = medial head of gastrocnemius, GL = lateral head of the gastrocnemius, SOL = soleus, TA = 
anterior tibialis, PER = peroneus and TP = posterior tibialis). 
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distinguishing between the causes of changes in DTI measures in skeletal muscle 
requires in vivo measurements of SNR, mean water T2 and % fat.
SNR as a confounding parameter 
with the overestimation of FA and the underestimation of MD and the eigenvalues in 
the low SNR ranges, are in line with our simulation experiment as well as with previous 
work. 20, 22 In a low SNR condition, an erroneously elevated measurement of anisotropy 
can occur even in highly isotropic structures. This previously reported phenomenon 
underlies the behaviour visible in the distributions of the DTI-parameters plotted 
against SNR. 30
1 3 and SNR when data points with an SNR>20 were considered, suggesting 
with predictions that for muscle-only regions of interest, an SNR of 20-25 is needed for 
5% accuracy in DTI parameter estimation and the required SNR level varies between 
DTI measures. 20, 22 A feature of Figures 2a-e is the high variation in SNR levels between 
the various data-points. The low SNR data are localized in particular subjects and could 
have been caused by movement during scanning, B0 shifts, and/or less available signal 
already challenging in muscle DTI in healthy controls, this will be even more the case 
in paediatric populations and patients (who may be more prone to discomfort during 
% fat as a confounding parameter
As the influence of fat infiltration and the effect of SNR on the DTI parameter 
estimation are interrelated, only datasets with SNR greater than 20 are used for 
this part of the analyses. Significant negative correlations were observed between 
3. As %fat increases with age in patients with DMD, it could be 
that these correlations are partly reflecting intrinsic diffusion changes occurring 
with progression of the disease. However, in previous work it has been shown that 
with the presence of fat tissue, even without any other physiological effect present, 
causes MD and the eigenvalues to be underestimated and FA to be overestimated. 
21, 22 These results are in agreement with our work as well as with the simulation 
experiment and suggest that the correlations observed here are most likely due to 
the confounding effect of %fat. However, as the observed correlations are weak and 
involve a majority of data points from low %fat values, the specific role that %fat has 
on the DTI measurements in patients with DMD remains unclear.
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T2 as a confounding parameter
2 found in all the lower leg muscles 
of the DMD patients compared to healthy controls, we showed no dependence of DTI 
parameters on water T2 changes. Taken by itself the increased water T2 in patients by 
~5 ms would increase the SNR by ~15%. However, due to the DMD pathology, this is 
accompanied  by an increase in fat fraction (~20%), which in turn reduces the SNR. 
Taken combined, this results in  no statistical correlation between increased T2 and 
SNR, and consequently no correlation with DTI-parameter estimation in patients with 
DMD. In addition,  simulation work has shown that  much larger increases in mean 
water T2
20
Between-Group Differences Determined by using all ROIs
Without taking into account any of the previously addressed confounders, between-
3 in the TA muscle and elevated 
mean FA values in the GL, SOL and PER muscles. These apparent differences in DTI 
parameters between groups could have multiple explanations. First, they could have 
resulted from changes in the intrinsic diffusion properties of muscle water due to 
pathology. Second, they could be due to the presence of confounding effects on the 
DTI measurements. As both low SNR and high %fat datasets are included in this part 
of the group analysis, it is most likely that the apparent increases in FA simply reflect 
low SNR, rather than changes in muscle microstructure. This conclusion is supported 
by previous experimental work that showed that FA is artificially increased in regions 
with significant fat-muscle partial volume artefacts. 21 However, the significantly 
3 in the TA muscle and the lack of any significant changes in MD 
or the eigenvalues in the other muscles are inconsistent with the effects predicted 
by low SNR and high fat levels. 2, 9, 31 One possible explanation for these elevated 
diffusivities in the TA is that the effect of pathology may be much stronger than the 
potential effect of confounders. Second, it might be that the estimation of MD and 
the eigenvalues – particularly when using WLLS for tensor estimation – is slightly 
less sensitive to the influence of noise. This is consistent with the prediction of 
simulation-based work. 20  Finally, it could be that MD and the eigenvalues are only 
affected in the higher fat fractions and that this DMD cohort did not contain many 
patients with highly fat infiltrated muscles. 
Between-Group Differences Determined by using only ROIs with SNR>20 
After accounting for SNR as a confounding effect, using only datasets with a 
SNR cut-off above 20, micro-structural changes are observed between groups. A 
3 in the TA and GL muscle of 
DMD patients were found. In contrast to the observations in the between-group 
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analysis using all datasets, no significant increases in FA were detected between 
groups when correcting for low SNR. As this between-group analysis is based on a 
smaller number of subjects than the analysis using all ROIs, this could have resulted 
in not finding changes in FA. This is in accordance with mouse skeletal muscle work 
3 have been reported as an immediate response to 
muscle injury. 17 At the same time, the observed trend for a decrease in FA combined 
with the increase in MD in the TA muscle is in agreement with common changes 
associated with muscle injury and damage. 2, 4, 17, 32, 33 However, as a consequence of 
not fully correcting for confounders it could be that both %fat and SNR have had a 
potential effect on the DTI parameter estimation. As the effect of both confounders 
3, it is likely that the observed changes 
in these DTI measures, in both between group analysis, are due to changes in the 
intrinsic diffusion rather than due to confounding effects. Therefore, the increased 
3 in the TA muscle is most likely reflecting the pathophysiology in patients 
with DMD. 
Previous studies
Besides the agreements found with clinical applications in diseased and damaged 
human skeletal muscle, there is to our knowledge one other clinical study which 
focused on skeletal muscle DTI in patients with DMD; that study reported a 
significantly increased FA and decreased MD with disease progression. 9, 31 These 
observations are to some extent in line with the results from our group analysis 
using all ROIs, to be precise with the detected significant increased FA in several 
muscles, which is likely caused by confounders, as both %fat and low SNR result in 
an overestimation of FA: no corrections for the confounding effects of SNR, %fat or 
T2 changes were made. 
Limitations
A few potential limitations of the study should be acknowledged. First of all, no 
distinction has been made between the six individual muscles during the evaluation 
of confounding effects on the DTI parameter estimation. All evaluations are based 
on the assumption that variations in DTI parameters between muscles are negligible. 
34 As previous studies have shown that the variations between muscles are minor 
compared to the changes detected due to confounding effects, we assume that 
these small variations between muscles will be outweighed by the larger effects 
of SNR, % fat and T2 changes. 
34 Secondly, as mentioned before a large amount 
of data has been excluded to retain quality for the between-group analysis using 
only ROIs with  SNR>20. This could potentially have resulted in not finding any 
differences in some of the DTI measures between the groups. A larger number of 
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subjects, combined with an even further optimized DTI protocol, will be advisable 
for future work. Lastly, the tri-exponential T2 fitting method has not yet been shown 
to produce equivalent water T2 estimates to fat-suppressed T2 methods.  In using 
this method, we are assuming that the effects of the confounding parameters on 
the DTI estimates are greater than any error or variability produced by using the tri-
exponential fitting approach. 
Conclusion
estimation of the DTI parameters in skeletal muscle and that in vivo measurements 
of % fat and mean water T2 are necessary to assess whether detected changes in DTI 
our work suggests that reliable DTI measurements in skeletal muscle can be obtained 
in DMD patients and healthy controls, while accounting for confounding factors. 
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The progressive replacement of muscle tissue by fat in Duchenne muscular dystrophy 
(DMD) has been studied using quantitative MRI between, but not within individual 
muscles. We studied fat replacement along the proximodistal muscle axis using the 
Dixon technique on a 3T MR scanner in 22 DMD patients and 12 healthy controls. 
Mean fat fractions per muscle per slice for seven lower and upper leg muscles were 
compared between and within groups assuming a parabolic distribution. Average fat 
fraction for a small central slice stack and a large coverage slice stack were compared 
to the value when the stack was shifted one slice (15mm) up or down. Higher fat 
fractions were observed in distal and proximal muscle segments compared to the 
muscle belly in all muscles of the DMD subjects (p<0.001). A shift of 15mm resulted 
in a difference in mean fat fraction which was on average 1-2% ranging up to 12% 
(p<0.01). The muscle end regions are exposed to higher mechanical strain, which 
points towards mechanical disruption of the sarcolemma as one of the key factors 
in the pathophysiology. Overall, this non-uniformity in fat replacement needs to 
be taken into account to prevent sample bias when applying quantitative MRI as 
biomarker in clinical trials for DMD. 
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INTRODUCTION
Duchenne muscular Dystrophy (DMD) is caused by a mutation in the DMD gene and 
is characterized by progressive muscle weakness. 1 Quantitative MRI is becoming 
increasingly important as a non-invasive method to follow disease progression, and 
is considered a promising surrogate outcome measure for clinical trials. 2 Assessment 
of fat replacement in individual muscles and in relation to clinical outcomes has been 
studied extensively by MRI. 3-17 
The fat fraction of a muscle is normally calculated from the average of several 
central slices in a muscle, 7, 8, 11 or of a specific region of interest. 17, 18 However, it is 
unknown if  fat is distributed uniformly over the muscle, and thus how robust this 
type of measurement is with respect to the exact location over which the images 
are quantified. For example, in Charcot-Marie-Tooth disease and Facio-Scapulo-
Humeral muscular dystrophy, it is known that fat replacement varies along the 
proximodistal axis. 19, 20 In DMD it is plausible that fat distribution is non-uniform, 
as dystrophin is non-uniformly distributed, 21 and mechanical strain is highest in the 
muscle end regions. 22-24 This non-uniformity potentially has a major effect on the 
calculated fat fraction, particularly since in longitudinal studies DMD boys inevitably 
grow in-between examinations and accurate repositioning is very challenging. In 
this study, therefore, we 1) assessed the distribution of fat replacement along the 
proximodistal muscle axis, and 2) determined the effect of a slight shift in spatial 
localization along the proximodistal muscle axis on the measured mean fat fraction 
in DMD boys using two commonly used approaches: analysis of a small central slice 
stack or volume 3, 4, 6, 10, 17 and analysis of a non-contiguous slice stack with a large 




Twenty-two DMD patients (mean age 9.3±3.1 years, range 5-16 years) and twelve 
healthy control subjects (9.7± 2.9 years, range: 5-14 years) participated in this study. 
Patients were recruited from the Dutch Dystrophinopathy database. 25 Exclusion 
criteria were MRI contraindications and the inability to lie supine for at least 30 
minutes. Diagnosis was confirmed by molecular genetic testing. Among the DMD 
patients, 16 were fully ambulant, 6 patients were wheelchair bound and all patients 
used corticosteroids with intermittent dosing regimens (varying between 8-10 days 
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on/off). Healthy controls were recruited from local schools and sport clubs. The 
study was approved by the local medical ethics committee, and written informed 
consent was obtained from all subjects and their parents.
2.2 MR methods
MR images were acquired in the right lower and upper leg on a 3T MR system 
(Ingenia, Philips Healthcare, Best, The Netherlands), using a 16-channel body receive 
coil array placed on top of the legs in combination with the 12-channel receive coil 
array located within the patient table. Patients were positioned in a feet first, supine 
position. The coil was placed on top of the leg in order to cover the full length of 
the upper and lower leg. In the taller boys, the coil had to be repositioned during 
scanning to ensure full coverage of the upper leg. The imaging protocol contained a 
3D survey scan for localization, transmit field (B1
+) calibration and 3-Point Gradient 
Echo Dixon to determine fat replacement (23 slices; voxel size 1x1x10 mm; interslice 
femur bone, and positioned in such a way as to provide maximal coverage of the 
muscles in the lower and upper leg. 
2.3 Data-analysis
Fat and water images were generated using a multi-peak model based on a six fat 
peak spectrum coded in Matlab (Mathworks, Natick, MA, USA). Values were not 
corrected for T2* relaxation effects. 
26, 27 The sequence was optimized with respect 
to TR and flip angle to avoid T1 relaxation effects. After reconstruction, visual 
inspection was used to assess image quality to detect reconstruction failure, B0 
artefacts and movement artefacts. Images with clear artefacts were removed from 
further analysis. 
Regions of interest (ROIs) were drawn manually using Medical Image Processing, 
Analysis and Visualization (MIPAV) software (http://mipav.cit.nih.gov) for seven 
individual lower and upper leg muscles for which full coverage of the muscle was 
achieved within the field-of-view of the Dixon scan, namely the soleus (SOL), the 
tibialis anterior (TA), the peronei (PER), the tibialis posterior (TP), the extensor 
digitorum longus (EDL), the vastus lateralis (VL) and the biceps femoris long head 
(BFL) muscle. ROIs were drawn on the reconstructed water images. The boundaries 
of the ROIs were chosen to always fall within a muscle in order to avoid contamination 
of subcutaneous fat and fatty intermuscular septa. In the more severely affected 
patients, both the reconstructed fat and water images were used to ensure that the 
boundaries of the ROI fell within the muscle. ROIs were only drawn on slices in which 
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the muscle was visible. Quantitative fat fractions were calculated as signal intensity 
(SI) fat/ (SI fat+ SI water))*100 from the reconstructed fat and water images and 
reported as a mean value of all pixels within a ROI. Fat fraction (%) was calculated per 
ROI and per slice. For visual comparison of fat distribution along the proximodistal 
muscle axis between subjects of different ages, all datasets were aligned according 
to their maximal cross-sectional area of the muscle (maxCSA).
2.4 Statistical Analysis
Generalized Estimating Equations (GEE) were used to assess the fat distribution 
pattern in both groups separately, assuming a parabolic curvature (ax2+bx+c). GEE 
was also used to assess differences in fat distribution pattern along the proximodistal 
muscle axis between DMD patients and healthy controls. GEE takes into account the 
repeated measurements within the same muscle (individual slices). 
Differences in mean fat fraction between measurement locations within an individual 
muscle were assessed using a paired t-test for a Small Coverage (SC) and Large 
Coverage (LC) analysis. For the SC analysis, the mean fat fraction was averaged over 
four central slices. The first location was at the thickest part of the calf or at mid-
thigh level. For the second and third location, the selection of slices was shifted one 
slice in the distal direction or one slice in the proximal direction in relation to the first 
location. All three locations along the proximodistal muscle axis covered the same 
distance (5.5 cm) of the calf. For the LC analysis, the mean fat fraction was averaged 
over 5 non-consecutive slices. The middle slice of the stack was positioned at the 
thickest part of the leg or at mid-thigh level for the first location. For the second 
and third location, the selection of slices was shifted one slice proximal and one slice 
distal in relation to the first location. All three locations along the proximodistal 
muscle axis covered the same distance (13 cm) of the calf.
Finally, a Bland-Altmann plot was used to assess the difference between the fat 
fraction calculated at the central slices versus fat fraction calculated over the whole 
muscle. A Bonferroni correction was applied to correct for multiple comparisons 
resulting in a significance level set of p<0.01 in the paired analysis and a significance 
level set of p<0.002 in the GEE analysis. Statistical analyses were performed using 




Full lower leg datasets were obtained in all DMD patients and healthy controls. Upper 
leg datasets were acquired in all healthy controls and in 16 DMD patients. In six DMD 
patients, the protocol could not be completed due to fatigue, patient discomfort 
in the supine lying position, or anxiety upon entrance into the scanner bore. Five 
upper leg datasets (two DMD patients and three healthy control subjects) and one 
lower leg dataset (HC subject) had to be excluded due to movement artefacts. In 
all cases, the two outer slices on both sides were excluded from the analysis due to 
reconstruction failure caused by B0 inhomogeneities.
3.1 Fat distribution over the entire length of the muscle
Within-group analysis showed that the fat distribution pattern along the 
proximodistal muscle axis was non-uniform in patients and controls. Higher fat 
fractions were observed in the more proximal and distal muscle parts compared to 
the maxCSA (Figure. 1; Figure. 2 a-b). The fat distribution pattern  could be well 
described by a parabolic curvature for all the analyzed muscles of the DMD patients 
(Range in a: 0.133-0.390; p<0.001), and healthy controls (range in a: 0.003-0.084; 
p<0.001), with the exception of the PER muscle (a= 0.003; p=0.858). Between-group 
Figure. 1 Fat reconstruction of the right lower leg of a DMD patient in the coronal and axial plane. Note 
the distribution of fat along the proximodistal muscle axis of the TA muscle (red arrows). Together with 
three axial fat-only images showing a distal, middle and proximal muscle section of the TA muscle 
visualized with a manually drawn ROI (red). The middle slice has, already visually, less fat replacement 
compared to the proximal and distal slice.
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Figure. 2
a slight shift in positioning. Fat fraction (% fat) as a function of location (cm) along the proximodistal 
muscle axis (a) for the SOL muscle (b)  and the VL muscle. The middle point of the graph is aligned with 
the maximal Cross Sectional Area (maxCSA) of the muscle in order to facilitate visual comparisons 
between subjects. The left direction shows the more distal muscle part while the right direction 
showed the proximal muscle part. Due to natural variation in length, as well as leg and muscle size, 
the amount of data points plotted on both sides of the maxCSA varied per subject and per muscle. 
Each line represents one individual subject. To increase the readability of the graphs DMD patients 
are grouped and colored according to their mean fat fraction. (red = HC subjects, black= %fat <20, 
dark grey= 20 <%fat>40, light grey=%fat> 40%).  This grouping according to mean fat fraction is only 
SOL muscle (d-f) and the VL muscle for the small coverage (SC) and large coverage (LC) analysis.  SC/
between mean fat fraction obtained at the thickest part of the calf or at mid-thigh level and obtained 
when shifted one slice in the proximal direction. Each grey square/dot represents one individual DMD 
DMD patients in the VL muscle together with the high variation when the analysis window was shifted 
one slice proximal or distal. 
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analysis showed a significantly more pronounced parabolic fat distribution pattern 
in DMD patients compared to healthy controls for all muscles analyzed (p<0.001), 
with exception of the BFL muscle (DMD a=0.133; HC a=0.084; p=0.176). 
3.2 Differences in fat fraction with a slight shift in positioning  
Shifting the slices which were analyzed by one slice either in the proximal or distal 
direction resulted in a significant difference in fat fraction for the majority of the 
muscles for both the SC and LC analysis. (Table. 1) The difference was on average 
1.7% and up to 12% for the SC analysis (Figure.2 c-d) and 1.7% ranging up to 10.7% for 
the LC analysis (Figure. 2 e-f).The Bland-Altman plot of the central slice fat fraction 
versus whole muscle fat fraction showed that the largest differences in mean fat 
fraction (i.e. between 0.13% and 22.24%) occurred in muscles with intermediate fat 
fractions (Figure. 2a,b; Figure. 3)
 
Figure. 3  
averaged fat fraction over the four middle slices. Each square represents one individual muscle of an 
fat fractions.
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DISCUSSION
Our results show that in DMD patients all analyzed leg muscles have a non-uniform 
fat distribution pattern along the proximodistal muscle axis, showing higher fat 
replacement near the origin and insertion of the muscle compared to the muscle 
belly. This specific pattern is also found in the muscles of the healthy control subjects, 
although significantly less prominent. 
The non-uniform fat fraction has important implications for the use of quantitative 
MRI or MR spectroscopy of fat replacement or muscle biopsies as biomarkers 
in clinical trials. 2 Our study has shown that a slight shift of 1.5cm along the 
proximodistal muscle axis results in significant differences in estimated mean fat 
fraction. Importantly, these differences are in the same range (SC analysis average: 
1.7% up to 12%; LC analysis average: 1.2% up to 11%) as changes found in fat fraction 
in longitudinal studies over an 12 or 18 month time period. 8, 11, 13-15, 17  Due to the 
parabolic shape of the fat distribution along the proximodistal muscle axis, a shift 
in slice spacing to either the proximal or the distal side of the muscle will result in 
an artificial increase of the measured fat fraction when the slice stack is positioned 
at the lowest point of the parabola. As a result, this sample bias is independent of 
the shift direction and cannot be averaged out. However, this is not always the case 
since usually slice stacks are positioned at a specific distance from a bony landmark. 
As this will not directly match to the lowest point of the parabola for each muscle, 
Muscle LC -- Distal LC -- Proximal SC-- distal SC- proximal
EDL 1.4 ±2.3 (0.04-6.9%) * 2.9±3(0.03-10.7%) -1.5 ±2.8 (0.06-12%) * 0.4±3.1(0.01-10.7%)
PER -0.2±2.9(0.17 -4.1%) 2.1±1.9 (0.7-7.8%) * -2.5±1.9 (0.12 -5.2%) * 1.4±3.6 (0.67-11.3%) *
SOL -1.0±2(0.03-3.7%) * 3.1±2.6 (0.01-3.26%)* -1±1.8 (0.03-6.1%) * -0.06±1.6 (0.01-3.26%)
TA 0.2±2.6 (0.16-9.3%) 2.3.±2.8 (0.4-8.4%)* -1.3±2.2 (0.16-9.1%) * -0.02±2.2 (0.02-5.3%)
TP 0.5±0.6(0.04-2.1%)* 0.9±0.8(0.07-3.37%)* -0.21±0.7 (0.04-2.1%) -0.2±1.1 (0.07-3.37%)
BFL 0.9±1.4 (0.03-4.4%) * 0.4±1.2 (0.15-3%) 0.7±1.7 (0.21-4.2%) * -1.6±2.2 (0.32-7%) *
VL 1.7±1.9 (0.25-6.2%)* 0.4±1.1 (0.02-1.7%) 1.0±1.5(0.04-3.96%) -1.6±1.6 (0.3-5%) *
Table. 1 The 
shift in location along the axis in the DMD patients for the large coverage (LC) and the small coverage 
of the calf or at mid-thigh level and obtained when shifted one slice in the distal direction. SC/LC  – 
indicated with *. Abbreviations: tibialis anterior (TA) and posterior (TP) extensor digitorum longus ( 
EDL), peroneal muscles (PER), soleus (SOL), vastus lateralis (VL) and biceps femoris long head (BFL)
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it is possible that the difference will be averaged out on a group level. Overall, this 
greatly diminishes the discriminant power of the technique and stresses the need for 
extreme accurate and reproducible spatial localization over time. 
Fat replacement is commonly assessed using MR by 2D or 3D imaging or MR 
spectroscopy. 7, 8, 11, 18 The intrinsic parameters involved in this methodology, i.e. slice 
gaps, slice thickness, field-of-view and restricted voxel size could result in limited and 
location-specific information on the fat fraction. In addition, due to the age of DMD 
boys in current clinical trials, boys will inevitably grow during the trial. Both aspects 
complicate spatial localization in a longitudinal study set up. Using a combination 
capsules placed on the skin is recommended to increase accuracy. 28, 29 Ultimately, a 3D 
acquisition that covers the whole limb will be the most robust method to acquire 
data in a longitudinal follow-up. The full coverage allows accurate offline matching 
of datasets. 
Another implication of the non-uniform distribution of fat with respect to the use 
of MRI in clinical trials is the less prominent parabolic curvature in muscles with 
either high or low fat fractions compared to intermediately affected muscles. 
These differences in parabolic curvature are most likely caused by evolution of the 
fat distribution pattern over time from a homogeneous initial phase (unaffected 
muscle) through a heterogeneous middle state (intermediate affected muscle)  to a 
homogeneous end stage (highly affected muscle). This effect can also  be visualized 
in the Bland-Altman plot, where more prominent differences in mean fat fraction 
between the central four slices versus the whole muscle fat fraction were observed 
in the intermediate affected muscles compared to the un-affected and highly 
affected muscles. Therefore, the highest bias due to sampling errors occurs in these 
intermediate affected muscles. However, these muscles in particular are the ones 
which are most likely to be useful as a surrogate endpoint in clinical trials, as they 
have the highest potential of showing a response to treatment via a decrease in the 
rate of progression of fat replacement. 
In addition to the clinical implications of measuring the non-uniform nature of the 
fat distribution, this type of measurement could help in the understanding of the 
underlying pathophysiology in DMD. In healthy skeletal muscle, mechanical strain is 
non-uniformly distributed along the proximodistal muscle axis, where higher strain 
is observed in the muscle end regions compared to the muscle belly. 23, 24, 30 In healthy 
mice, dystrophin has been shown to be particularly concentrated near these end 
regions 31 in contrast to other proteins associated with mechanical stability such as 
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connectin and nebulin. 32 In addition, dystrophin-deficient muscles are especially 
susceptible to stretch-induced muscle injury.33, 34 It therefore seems logical that 
mechanical disruption of the membrane might be one of the key causative factors for 
muscle degeneration, and for fat replacement in DMD to evolve more prominently 
in the end regions compared to the muscle belly. 
Our study had some limitations. In the reconstruction of the three-point Dixon 
images, no T2* correction was applied which could result in an overestimation of the 
fat fractions in the low fat ranges. 27 However, as this will result in artificially high fat 
fractions in the low fat range, correcting for T2* would only result in an even more 
pronounced parabolic curvature. Secondly, in this work only the seven lower and 
upper leg muscles of which full coverage could be ensured have been analyzed. In the 
upper leg in particular the field-of-view was not large enough to cover entire muscles 
and the B0 artefacts near the joints prevented analysis of bi-articular muscles. This 
could have resulted in a selection bias towards shorter mono-articular muscles in 
which strain might be distributed differently than in longer muscles. Thirdly, the 
relatively young study population resulted in a majority of less and intermediate 
affected muscles which has an influence on the average parabolic curvature used as 
an outcome measure. 
To conclude, we have shown a clear non-uniform fat replacement pattern along the 
proximodistal muscle axis in DMD within individual lower and upper leg muscles. 
This non-uniformity in fat fraction within an individual muscle has a major influence 
on quantitative MR measurements and biopsy parameters that are currently 
considered as outcome measures in clinical trials, and highlights the need for 
accurate repositioning in longitudinal studies. A slight shift along the proximodistal 
muscle axis results in a difference in fat fraction which is on average 1-2% ranging up 
to 12%. These differences are most prevalent in the muscles with intermediate fat 
fractions. In addition, these findings seem to point to mechanical disruption of the 
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Elevated  phosphodiester and T2 levels 
can be measured in the absence of 
fat infiltration in Duchenne muscular 
dystrophy patients 
M.T. Hooijmans , E.H. Niks, J. Burakiewicz, J.J.G.M Verschuuren, A.G. Webb, H.E. Kan





Quantitative MRI and MRS are increasingly important as non-invasive outcome 
measures in therapy development for Duchenne muscular dystrophy (DMD). Many 
studies have focussed on individual measures such as fat fraction and metabolite 
levels in relation to age and functionality, but much less attention has been given 
to how these indices relate to each other. Here, we assessed spatially-resolved 
to the degree of fat replacement compared to healthy controls. Quantitative MRI 
and 2D-CSI 31P MRS scans were obtained from eighteen DMD patients and twelve 
healthy controls using a 3T and a 7T MR scanner. Metabolite levels, T2 values and 
extensive fat replacement, phosphodiester over ATP (PDE/ATP) inorganic phosphate 
over phosphocreatine (Pi/PCr), intracellular tissue pH and T2
increased compared to healthy controls. In contrast, in muscles without extensive 
fat replacement, only PDE/ATP and T2
our results show that PDE levels and T2 values increase prior to the occurrence of fat 
replacement and remain elevated in later stages of the disease. This suggests that 
these individual measures could not only function as early markers for muscle damage 
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Introduction
Duchenne Muscular Dystrophy (DMD) is an X-linked disease caused by a mutation in 
the DMD-gene, affecting approximately 1 in 3500 male new-borns. 1 The absence of a 
functional dystrophin protein in the muscle cells of DMD patients manifests itself in 
progressive muscle weakness, functional loss, and cardiac and respiratory failure. 2 
Within muscle tissue different pathophysiological events, such as changes in energy 
metabolism, fat infiltration, oedema and fibrosis, take place simultaneously. 3 The 
time course of these various processes is not fully understood but it appears that 
initial inflammation, and changes in energy metabolism, are eventually followed by 
the replacement of muscle tissue by fat and fibrotic tissue. It is generally thought 
that fat replacement of muscle tissue is irreversible while other processes may be at 
least partially reversible. 
Both MRI and MRS have been used to non-invasively map these individual 
pathophysiological processes in DMD. 4-7 Muscle replacement by fat is commonly 
determined by chemical shift based methods such as Dixon. This replacement 
correlates well with age, disease progression and functional measures. 8-11  Another 
MR parameter which is frequently used in DMD is the T2, which reflects both fat 
replacement and inflammation/edema. If used without correcting for the presence 
of fat, these relaxation times are referred to as global T2 values and display the same 
progressive course as the fat fraction. 12-14 In addition, it is possible to assess the 
individual T2 relaxation times of fat and water. The water T2 is thought to represent 
the inflammation component, and is elevated compared to healthy controls. 4, 
15-17 In contrast to global T2 values, water T2 values decrease with age and disease 
progression, most likely inversely related to the increase of fibrotic tissue. 18 Finally, 
metabolic changes in the muscles of DMD patients can be detected by using 
phosphorous spectroscopy (31P-MRS). Reduced phosphocreatine (PCr) levels which 
have been associated with loss of metabolic activity, elevated phosphodiester levels 
(PDE) which might be directed related to membrane anomalies and a more alkaline 
pH associated with leaky myocytes have been detected in DMD patients compared 
to healthy controls. 6, 19-22 Furthermore, the PCr over inorganic phosphate (Pi) ratio 
has been shown to decline with age while the PDE/ATP ratio increased with age. 22, 23
Until now most MR studies have focussed on individual MR parameters, and little 
attention has been given to how these indices relate to each other.  In particular, the 
temporal relation between changes in metabolic parameters, obtained from 31P MRS, 
and changes in fat fraction and water T2 assessed with quantitative MRI is unclear. 
In Becker Muscular Dystrophy (BMD) structural changes such as the replacement 
of muscle tissue by fat and fibrosis are predominantly present in later stages of 
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the disease, while metabolic changes occur earlier. 24 This suggests that metabolic 
changes precede fat replacement. In contrast, work in facioscapulohumeral 
dystrophy (FSHD) patients showed that metabolic changes were only present 
in muscles with extensive fat replacement, which suggests that in this muscular 
dystrophy, metabolic changes and fat replacement occur simultaneously. 25 Finally, 
recent work in the arm muscles of DMD patients indicated a linear relation between 
fat fraction and disease progression, while metabolic changes most likely show 
non-linear behaviour. 26 Taken together, this body of work highlights the fact that 
it is important to assess more than just one aspect of muscle damage in DMD for a 
better understanding of the time course of the pathophysiology.  In order to do this, 
it is essential that different measures be spatially co-localized in order to compare 
the results. However, 31P MRS in DMD is commonly performed using surface coil 
localization, which makes it difficult to combine the results from spatially-resolved 
proton imaging and non-spatially-resolved MRS. The availability of higher field 
strength magnets creates the possibility to obtain high quality and muscle specific 
31P MRS data within reasonable measuring times.
In this work, we present combined quantitative MRI and spatially-resolved (2D-CSI) 
31P MRS data of the leg muscles in DMD patients to determine metabolic changes 
and inflammation in muscles with and without fat infiltration to assess if metabolic 
changes and inflammation vary in different stages of the disease process.
Methods
Study population
Eighteen DMD patients (Age: 9.2± 3.7 yrs.; range: 5-16 yrs) and twelve age matched 
healthy control subjects (Age: 9.7± 2.9 yrs.; range: 5-14 yrs)  participated in this 
study. All healthy subjects were recruited from local schools and sport clubs, while 
all patients were recruited from the Dutch Dystrophinopathy Database. 27 All 
DMD diagnoses were confirmed by genetic testing. Fourteen DMD patients were 
ambulant, and four patients were wheelchair-bound. All patients used corticosteroids 
with intermittent dosing regimens, which varied between 8-10 days on/off. The local 
medical ethical committee approved the study and all subjects and/or their parents 
signed informed consent.
MR Examination
All 31P datasets were acquired on a Philips 7T Achieva MR system (Philips Healthcare, 
The Netherlands) with a custom-built double-tuned birdcage coil. Patients were 
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positioned in a supine position, feet first in the scanner. The coil was positioned 
around the left lower leg, at the thickest part of the calf directly distal to the patella. 
The imaging protocol contained a gradient echo FISP sequence for anatomical 
imaging (15 slices; slice thickness 7mm; interslice gap 0.5 mm; repetition time (TR) 
FOV 160x180 mm) and a 2D phosphorous MRS Chemical Shift Imaging (CSI) dataset 
to assess skeletal muscle energy metabolism (FOV 200x200/150x150 mm; matrix 
12 signal averages at the central k-lines). No slice selection was applied.  31P data 
were measured over the entire length of the coil which covered 12 cm of the leg in 
the feet/head direction. Second order shimming was applied with an image based 
shimming routine. The 2D-CSI positioning was guided by the  anatomical images. 
As the diameter of the lower leg and the boundaries between the different muscle 
groups change along the length of the leg, the 2D-CSI sequence was planned in 
such a way that within the volume of the coil a specific voxel was located within one 
individual lower-leg muscle. 24
On the same day, quantitative imaging datasets were acquired at 3 Tesla. A 3-point 
gradient echo Dixon sequence was acquired of the same leg on a Philips 3T Ingenia 
MR system for fat quantification in the lower leg (23 slices; slice thickness 10 mm; 
In addition,  a multi turbo spin echo sequence (MSE) was acquired to determine the 
mm; gap 20 mm; slice thickness 10 mm; 5 slices, no fat suppression, refocussing 
pulse shape: central part of a sinc function , CPMG condition). The middle of the slice 
stack was positioned on the thickest part of the calf directly distal to the patella, to 
ensure accurate co-localisation with the 31P data set.
 
Data-analysis
All phosphorous data sets were visualized with the 3D Chemical shift imaging 
package (3DiCSI). Individual spectra were identified in 5 lower leg muscles; the 
lateral (GL) and medial (GM) head of the gastrocnemius muscle, the soleus muscle 
(SOL), tibial anterior muscle (TA) and peroneus (PER) muscle with a grid overlay 
on the anatomical image. Voxels were carefully positioned to avoid overlap with 
adjoining muscles. All individual free induction decays were exported and  processed 




corrected for partial saturation using literature values. 29 In addition, prior knowledge 
24 To calculate 
intracellular tissue pH, the shift in resonance between the Pi peak and PCr peak was 
used: pH=6.75 + log((3.27-S)/(S-5.69)). 30 As the disease progression in DMD patients 
is characterized by replacement of muscle tissue with fat, spectra of several patients 
suffered from a low signal-to-noise ratio (SNR) due to the low amount of muscle 
tissue in the voxel. To ensure spectral quality, SNR values were determined for each 
spectrum. Noise was defined as the standard deviation of the residual signal after 
the fitting procedure. Only spectra with SNR greater than 10 for the PCr peak in 
combination with the ability to properly fit all other metabolites were accepted. 
Quantitative fat fractions were generated from 3-point Dixon images using (SI) fat/
(SI fat+ SI proton))*100 according to a multi peak model containing six peaks. 31 
As the sequence was optimized with respect to TR and FA for minimization of T1 
relaxation effects, no correction for different T1 values was needed.32 The sequence 
was not corrected for T2* relaxation. 
33, 34
T2 values were calculated from the MSE images according a tri-exponential fitting 
routine written in Matlab (Mathworks, Natick, MA, USA)  based on a previously 
described method. 35 The assumed T2 fat values part of the tri-exponential fitting 
model were individually determined for each of the datasets.  No B1
+ sorting was 
applied, as B1+ maps were analysed and almost all voxels fell within the general 
rejection criteria set for T2 quantification (B1
+ lies in the range of 80-130% of the 
nominal B1+ set by the scanner)  Regions of interest (ROI) were drawn for the five 
individual lower leg muscles on all the slices within the coverage of the 2D-CSI 
using Medical Image Processing Analysis and Visualization (MIPAV) software (http://
mipav.cit.nih.gov). T2 and fat fraction are presented as a mean value of all pixels 
within a ROI over multiple slices. All muscles of DMD patients were classified into 
two groups according to their fat fractions:  Non-fat-infiltrated (NFI) DMD patients 
and fat-infiltrated DMD patients (FI DMD). Cut-off levels were determined for each 
muscle individually,  using the mean fat fraction + 2* SD of that specific muscle in 
HC subjects.
Statistical analysis
A general linear model was used to compare Pi, PCr, PDE, ATP and pH  and T2 levels 
between groups for the five lower leg muscles. Age was entered as a covariate. 
Statistical analyses were performed in SPSS version 20 for Windows (SPSS Inc., 
Chicago) and the level of statistical significance was corrected for multiple testing 
and set at (p<0.002). After which a post-hoc analysis was used to assess which groups 
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(HC subjects, NFI and FI DMD patients) were different. Fischer’s Least Significant 
Difference (LSD) model was used to correct for multiple comparisons during post-
hoc analysis, significance level was set at (p<0.05).
Results
Reconstructed T2 maps and corresponding fit of one of the voxel of the three 
analysed slices are visualized in Figure 1. Examples of 3T images and 31P spectra of a 
non-fat infiltrated DMD patient, a fat infiltrated DMD patient and a healthy control 
subject are depicted in Figure 2. For the healthy controls, all the spectra reached 
the quality control criteria. For the DMD patients, 16 out of 90 spectra had to be 
excluded due to lack of sufficient quality (GL=6/18; GM 4/18; SOL= 1/18; TA=3/22; 
PER=2/18). 
Figure 1.
showing the 1st echo (TE: 8ms) of the three inner slices (a,d,g); the reconstructed T2 map of those 
stimulated echoes. TE = echo timo (ms) and a.u. are arbitrary units.
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Metabolite ratios classified according to fat fraction
For the analysed muscles the NFI/FI DMD subgroups were divided as follows; GL NFI 
n=5/ FI n=7 (cut-off fat fraction 11.37%), GM NFI n=6/ FI n=8 (cut-off 10.05%), PER 
NFI n=4/ FI n=12 (cut-off 12.62%), SOL NFI n=7/ FI n=11 (cut-off  9.64%), TA NFI n=7/ 
FI n=8 (cut-off 10.81%). Metabolite ratios, T2 values and fat fractions for the healthy 
controls and NFI and FI DMD patients are shown in the supplemental data (Table.1).
Compared to healthy controls, PDE/ATP levels were significantly increased in the 
NFI and FI DMD group for all lower leg muscles (p<0.05), except for the PER muscle 
in the NFI DMD group (p=0.19)(Figure 3a). T2 values were significantly increased in 
both the NFI and FI group in all muscles compared to healthy controls, except for 
the TA muscle in the NFI group (Figure 3b). In addition, intracellular tissue pH was 
significantly increased in the FI DMD group compared to healthy controls for all 
muscles (p<0.01), while in the NFI group the PER and TA muscle showed significantly 
increased pH levels. (Figure 4b)  Pi/PCR was significantly elevated in the GL, SOL 
Figure 2. Axial images of the right  lower leg of a FI DMD patient (a-c), NFI DMD patient (d-f) and a HC 
lower leg muscles - medial and lateral head of gastrocnemius (GM, GL), soleus (SOL), anterior tibialis 
(TA) and the peroneus (PER) muscles. (b, e, h); the 7th echo of a multi-spin-echo image (TE: 56 ms);(c, 
f, i) a representative 31P spectrum for a FI DMD patient [c] NFI DMD patient [f]  and a healthy control 
subject [i].  Note the reduction in SNR in the phosphorous spectrum of the DMD patient. 
75
Elevated PDE levels and T2 levels prior to fat infiltration in DMD
4
Figure 3. Mean values ±SD for PDE/ATP (a) and T2
(PDE = phosphodiester, ATP=adenosine triphosphate, GL/GM= lateral and medial head gastrocnemius, 
PER= peroneus, SOL=soleus, TA=anterior tibialis)
Figure 4.
phosphate, PCr = phosphocreatine, GL/GM= lateral and medial head gastrocnemius, PER= peroneus, 
SOL=soleus, TA=anterior tibialis)
Figure 5. 
(Pi = inorganic phosphate, PCr = phosphocreatine, ATP=adenosine triphosphate,  GL/GM= lateral and 
medial head gastrocnemius, PER= peroneus, SOL=soleus, TA=anterior tibialis)
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and PER muscle in the FI DMD group and in the SOL muscle in the NFI DMD group 
compared to healthy controls (Figure 4a). Pi/ATP was elevated in the SOL muscle 
for the FI group compared to healthy controls (Figure 5a).  PCr/ATP was reduced in 
both the NFI and FI DMD group for the TA muscle compared to healthy controls. No 
changes were found for the other muscles (Figure 5b). 
In the comparison of the FI groups versus the NFI group, only  PDE/ATP was 
significantly elevated in all muscles, with exception of the SOL muscle. (p<0.05) 
In addition, T2 values tended to be higher in NFI group compared to the FI group, 
NFI and FI DMD group for the other metabolites.
Discussion
In this study we used a combination of quantitative proton MRI and localized 31P MR 
spectroscopy to evaluate high-energy phosphate levels and T2 in DMD patients in 
muscles with and without fat replacement. By assessing 31P metabolites at 7 tesla, 
we were able to localize the  metabolic changes within individual muscles. Since in 
DMD (and many other muscular dystrophies muscles) tissue is replaced with fat at 
different rates and at different time points,  the muscle specific multi parametric 
datasets obtained allows the evaluation of these pathophysiological processes in 
different disease stages.
Metabolic changes in the absence of fat
In DMD, it is thought that persistent inflammation due to muscle damage eventually 
results in replacement of muscle tissue with fat and fibrosis. 36 Consequently, indices 
which are sensitive to changes before fat replacement occurs are very valuable. 
Our results showed that PDE levels and T2 values are already elevated compared to 
controls in muscles without increased fat levels. PDE levels have been hypothesized 
to reflect phospholipid membrane degradation products which in some situations 
proved to be reversible, while elevated T2 values are attributed to changes in the 
extracellular and vascular spaces and are generally thought to reflect inflammation. 
18, 37-39 Together these results suggest that these individual measures can reflect 
muscle damage prior to the more apparent structural changes. This is in accordance 
with previous work in DMD and BMD patients where elevated PDE levels were 
detected prior to structural changes. 17, 24 In addition, higher PDE/ATP levels were 
observed for all muscles in the FI DMD group compared to the NFI DMD group, with 
exception of the SOL muscle. This suggests that it might reflect the progressive 
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behaviour of the disease. This is in agreement with previous work which compared 
metabolic changes between patient groups and showed even higher PDE levels 
in DMD patients compared to BMD patients and DMD carriers. 19, 40 Interestingly, 
PDE showed to be one of the most responsive 31P indices to AVV exon skipping 
treatment in the forelimb of GRMD dogs, changing towards more healthy values. 
41 Subsequently, the elevated T2 values in the absence of fat detected here are in 
agreement with previous work in DMD patients, showing increased water T2 levels 
in combination with low fat fractions in the Vastus Lateralis and Soleus muscle. 42 To 
monitor potential therapeutic effects, the ability to distinguish between affected 
and less affected muscle tissue in combination with the ability to revert back to 
normal values are important features of a surrogate biomarker. 
In addition to the metabolic changes, T2 values were lower in all muscles with 
fat infiltration compared to the muscles without fat infiltration, although not 
significantly. This phenomenon is often mentioned in the MR literature and has 
mainly been attributed to the increase in fibrotic tissue in later stages of the disease. 
17, 43
which gradually start to increase after the age of  6. 44 Interestingly, T2 values have 
been shown to decrease in response to three months of corticosteroid therapy in DMD 
patients.15 In combination with the natural course of T2 in DMD this indicates that T2 
as potential outcome measure is primarily valuable in the early phases of the disease.
Metabolic changes in the presence of fat
in addition to   PDE/ATP and T2 values, both Pi/PCr and intracellular tissue pH were 
for the often-reported more alkaline intracellular tissue pH in muscular dystrophies 
is unclear. Two processes have been suggested to be involved; i.e. an altered proton 
+ and increased 
mitogenesis due to continuous muscle regeneration in DMD. The increase in Pi/
PCr most likely is linked to elevated ADP concentrations due to poor coupling of 
the oxidative phosphorylation in resting muscle. 19, 22, 40 Interestingly, no consistent 
changes were found for Pi/ATP and PCr/ATP compared to controls. Up to now, all 
This contrast could be related to the studied DMD study populations. Most previous 
MR data have been obtained in older non-steroid treated DMD populations by using 
was obtained relatively early in the disease course. 6, 17, 21, 22, 26, 40
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Almost no differences were detected between NFI and FI DMD group for Pi/PCr, Pi/
ATP, PCr/ATP and pH which suggest non-progressive behaviour of these metabolic 
changes. This finding is partly in agreement with recently published longitudinal 
31P MRS data in the arm muscles of DMD patients which showed that none of the 
metabolic indices changed linearly with age. 26 The fact that Pi, PCr and intracellular 
tissue pH are predominantly changed in the presence of fat points out that these 
various processes might occur simultaneously. Fat fraction reflects loss of muscle 
tissue whereas metabolic changes, as they are solely detected in muscle tissue, are 
thought to reflect the quality of the remaining muscle tissue. These simultaneous 
processes yield complementary information and stress the importance of assessing 
multiple aspects of muscle damage in both early and later stages of the disease. 
Taken combined, our results provide more insight in the time relation between the 
various pathophysiological processes which take place in muscle; as PDE/ATP and T2 
are elevated in the absence of fat, these might be the first signs of damage detectable 
with MR. Thereafter,  apparently intracellular tissue pH and Pi/PCr become altered, 
as they are predominantly found in muscles with fat infiltration. Simultaneously with 
these metabolic changes, muscle tissue is replaced by fat and fibrotic tissue which 
is reflected by increased fat levels compared to controls and an apparent decrease 
in T2 values. Finally, we showed only minor changes in muscle Pi/ATP and PCr/ATP. 
Suggesting that these metabolites remain relatively well preserved in the early 
disease stages. Based on previous work it seems that in later disease stages, muscle 
energy metabolism becomes increasingly misbalanced after which Pi/ATP and PCr/
ATP also show changes. 6, 19, 22, 26 It is highly probable that this imbalance in energy 
metabolism will increase until all muscle tissue is replaced by fat and fibrotic tissue. 
Limitations
Some limitations of the study should be acknowledged. First of all, a large number 
of spectra (16 out of 90) had to be discarded due to insufficient quality as a result of a 
low SNR in muscles with extensive fat replacement. This could have resulted in some 
bias in regards to the less severely affected muscles. However, as metabolic changes 
which were present in muscles without fat replacement were even more pronounced 
in muscles with fat replacement, we do not think that any changes that were present 
went undetected. Secondly, the identification of  voxel solely in an individual muscle 
is somewhat complicated  using a 2D-CSI sequence as the diameters of the muscle 
change along the length of the leg. To circumvent this problem, the  anatomical 
images  used to plan the 2D-CSI sequence were carefully checked to ensure that one 
voxel was located within one individual muscle over the full length of the coil prior to 
starting the scan. Thirdly, no B1
+ correction was used for the tri-exponential T2 fitting 
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method applied here, which could have resulted in some bias in the determination 
of the T2 values in areas with low B1
+. However, this seems to be particularly the case 
for the upper leg, 45 whereas due to the smaller dimensions the problem seems to 
be less pronounced in the lower leg. 46 Lastly, quantitative imaging datasets were 
acquired at 3T, while MRS data were acquired at 7T. To minimize localization errors 
as much as possible, the FISP sequence used for carefully positioning the 2D-CSI at 
the 7T was also assessed to select the corresponding slices on the 3-Point Gradient 
Echo Dixon and T2 MSE acquired at the 3T system. 
Conclusion
In conclusion, our results show that with the combination of quantitative proton MRI 
and localized 31P MR spectroscopy we were able to distinguish between early and late 
pathophysiological changes in DMD patients. Both PDE levels and T2 values are not 
only already changed prior to the presence of fat infiltration, but remain elevated 
in more severely affected muscles. This suggest that these measures could not only 
function as early markers for muscle damage, but could also reflect a potentially 
reversible pathology in more advanced stages of the disease.  Future work will aim 
to assess spatially localized longitudinal multimodal MR measures in DMD to be able 
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Elevated PDE levels and T2 levels prior to fat infiltration in DMD
4
pH 7.01±0.01 7.05±0.01* 7.07±0.01*
T2 (ms) 34.2±0.7 36.9±0.97* 37.4±0.7*
Fat fraction(%) 10.2±1.2 12.2±0.6 38.7±21.2
SOL n= 12 n= 7 n= 11
Pi/ATP 0.35±0.02 0.41±0.03 0.48±0.02*
Pi/PCr 0.1±0.01 0.13±0.01* 0.15±0.01*
PCr/ATP 3.34±0.12 3.13±0.16 3.3±0.12
PDE/ATP 0.06±0.02 0.16±0.04* 0.22±0.03*
pH 7.03±0.01 7.04±0.01 7.09±0.01*$
T2 (ms) 35.3±0.9 41.2±1.2* 38.6±0.9*
Fat fraction(%) 7.8±1.9 10.7±1.5 43.5±16.3
TA n= 12 n= 7 n= 8
Pi/ATP 0.28±0.04 0.33±0.03 0.45±0.02
Pi/PCr 0.12±0.01 0.15±0.04 0.12±0.03
PCr/ATP 3.59±0.10 2.9±0.16* 3.02±0.12*
PDE/ATP 0.07±0.01 0.11±0.02* 0.16±0.02*$
pH 7.01±0.01 7.04±0.01* 7.06±0.01*
T2 (ms) 34.1±0.7 36.4±0.9 37.9±0.7*
Fat fraction(%) 8.2±1.3 8.9±1.2 30.1±8.9
Table 1. 
patients are marked with a dollar sign ($). (Pi = inorganic phosphate, PDE = phosphodiester, PCr = 
phosphocreatine, ATP=adenosine triphosphate GL/GM= lateral and medial head gastrocnemius, PER= 
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Objectives: To assess the changes in phosphodiester (PDE)-levels, detected by 31P 
magnetic resonance spectroscopy (MRS), over 24-months to determine the potential 
of PDE as marker for muscle tissue changes in Duchenne Muscular Dystrophy (DMD) 
patients. 
Methods: Spatially resolved phosphorous datasets were acquired in the right lower 
leg of 18 DMD patients (range: 5-15.4 years) and 12 age-matched healthy controls 
(range: 5-14 years) at three time-points (baseline, 12-months, and 24-months) using 
a 7T MR-System (Philips Achieva). 3-point Dixon images were acquired at 3T (Philips 
Ingenia) to determine muscle fat fraction. Analyses were done for six muscles that 
represent different stages of muscle wasting. Differences between groups and 
time-points were assessed with non-parametric tests with correction for multiple 
comparisons. Coefficient of variance (CV) were determined for PDE in four healthy 
adult volunteers in high and low signal-to-noise ratio (SNR) datasets. 
Results: PDE-levels were significantly higher (two-fold) in DMD patients compared 
to controls in all analyzed muscles at almost every time point and did not change 
over the study period. Fat fraction was significantly elevated in all muscles at all 
timepoints compared to healthy controls, and increased significantly over time, 
except in the tibialis posterior muscle. The mean within subject CV for PDE-levels 
was 4.3% in datasets with high SNR (>10:1) and 5.7% in datasets with low SNR. 
Discussion and Conclusion: The stable two-fold increase in PDE-levels found in 
DMD patients in muscles with different levels of muscle wasting over 2-year time, 
including DMD patients as young as 5.5 years-old, suggests that PDE-levels may 
increase very rapidly early in the disease process and remain elevated thereafter. The 
low CV values in high and low SNR datasets show that PDE-levels can be accurately 
and reproducibly quantified in all conditions. Our data confirms the great potential 
of PDE as a marker for muscle tissue changes in DMD patients.
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Introduction
Duchenne Muscular Dystrophy (DMD) is an X-linked disease caused by a mutation in 
the DMD gene which codes for the protein dystrophin. The absence of dystrophin in 
the muscle cells results in progressive muscle weakness and muscle damage which 
is reflected by changes in energy metabolism, inflammation, fibrosis and eventually 
by progressive replacement of muscle tissue by fat. 1 Although numerous clinical 
trials have so far led to conditional approval of a few compounds by the Food and 
Drug Administration (FDA) and European Medical Association (EMA), there is still an 
urgent need for more effective therapies and outcome measures in DMD. 2 
Quantitative magnetic resonance imaging (MRI) and spectroscopy (MRS) of muscle 
are becoming increasingly important as potential outcome measures for therapeutic 
evaluations in DMD, with both fat fraction (%fat) and water T2 being commonly used. 
3 Therapy development aims to improve or preserve the quality of the muscle tissue. 
In order to inform about muscle tissue itself, a marker should reflect changes within 
the muscle and should have sufficient discriminative power. Unfortunately, neither 
%fat nor water T2 fulfill these criteria. While %fat correlates well with function, 
it reflects the replacement of muscle by fat and therefore does not allow any 
statement on muscle tissue itself. 4-6 Water T2 has a closer relation with muscle, as it 
reflects inflammation and/or edema-like processes in this tissue. However, it has a 
low discriminative ability in DMD due to the use of corticosteroids – the difference in 
water T2 from a corticosteroid-treated boy with DMD and a healthy control is close 
to the detection limit of any difference. 7
Assessment of energy metabolism in muscle using phosphorous (31P) spectroscopy 
(MRS) has shown differences between healthy controls and DMD patients. 8-11 
As the concentration of the metabolites visible with 31P MRS is negligible in 
fat, this measurement almost exclusively measures muscle tissue. A broad 
variety of metabolic changes have been shown in DMD muscles, of which 
phosphodiesters (PDE) are especially interesting as a marker. PDE-levels are 
generally associated with membrane degradation products, and they are thought 
to reflect muscle membrane damage. 12 PDE levels have been shown to be 
elevated in the absence of increased fat%, and to remain elevated in more 
severely affected muscles in DMD. 13-15  They also revert back to normal after 
adeno-associated virus (AVV) vector therapy in Golden Retriever Muscular Dystrophy 
(GRMD) dogs, a canine model for DMD. 16 However, longitudinal assessments using 
31P MRS in DMD are very limited and hence it is unknown how PDE changes over 
time in the same individual muscle.14 Since muscles in DMD patients become 
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affected at different time-points and at different rates it is essential to perform 
muscle specific measurements. 17, 18 
The overall aim of this work was to assess the time course of changes in 
phosphodiester (PDE)-levels detected by 31P MRS in individual muscles over a 
2-year time period, using spatially resolved 31P MRS and quantitative Magnetic 
Resonance Imaging (qMRI) of lower leg muscles that represent different levels of 
muscle wasting. Because in DMD and many other muscular dystrophies muscle 
tissue is progressively replaced with fat, which directly reduces the SNR, we also 
aimed to assess the variability and accuracy of PDE-level quantification between 
two measurements. In addition, the effect of SNR on quantifying PDE-levels was 
assessed. Finally, the course of the Pi, PCr, ATP concentrations and intracellular 
tissue pH over two-year time-period were assessed with a post-hoc analysis. Our 
results show that PDE-levels were increased two-fold compared to healthy controls 
in muscles with different disease stages at virtually all time-points and did not 
change over a two-year period. The low CV and coefficient of reproducibility (CR) 
values in high and lower SNR datasets showed that PDE-levels can be accurately 




DMD patients were recruited from the Dutch Dystrophinopathy Database 19 and all 
9.8±2.6; range:5.5-15.4yrs.) and 12 healthy age-matched controls (mean:10.3±2.8; 
range:5-14yrs.) completed the baseline visit, 15 DMD patients (mean:10.2±2.9; 
range:6.5-16.4yrs.) and 10 healthy controls (mean:10.8±2.7; range:5-15yrs.) completed 
the 12-month follow-up, and 12 DMD patients (mean:9.85±2; range:7.5-17.7yrs.) and 
10 healthy controls (mean:12.1±2.6; range:5-16yrs.) completed the 24-month follow-
up. Among the DMD patients, 13 were ambulant throughout the entire study, and 5 
were wheelchair bound at baseline. All used corticosteroids with intermittent dosing 
between the baseline and 12-month follow-up visit. The study was approved by the 
local medical ethical committee of Leiden University Medical Center and written 
informed consent was obtained from all patients and parents. Participant recruitment 
started June 2013.
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In addition, for quality control purposes only, a total of 4 male healthy control 
subjects (age range: 33-82yrs.) were included in the study and scanned twice on the 
same day to assess reproducibility. All subjects gave written informed consent. 
MR Examination
31P MRS datasets were obtained from the right lower leg using a 7T MR scanner (Philips, 
Achieva, Best, The Netherlands) with a custom-built double (31P and 1H) tuned volume 
The coil was placed at the thickest part of the calf directly distal to the patella, and 
scans were aligned with the tibia bone. The imaging protocol contained a 2D-Chemical 
Shift Imaging (CSI) dataset to assess energy metabolism (FOV 200x200/150x150 mm; 
with 12 signal averages at the central k-lines), a B0 map as input for an image based 
shimming routine shimming (14 slices; slice thickness 8 mm, no slice gap; Repitition 
sequence for anatomical localization (15 slices; slice thickness 7mm; interslice gap 0.5 
was applied in feet/head direction for the 2D-CSI. As a result, 31P signal was measured 
over the full length of the coil, which covered 12 cm of the lower leg. The T1-weighted 
sequence was used to plan the 2D-CSI in such a way that one individual voxel was 
located within one muscle over the entire length of the coil, taking into account that 
the diameter and boundaries between individual muscles and muscle groups change 
along the length of the lower leg. The survey and the T1-weighted sequence were used 
as a reference to position the subject, and to plan the imaging stack as accurately as 
possible between the three subsequent time-points. On the same day, 3-point DIXON 
(Philips Ingenia, Best the Netherlands) with an anterior 16-element receive array and 
12-element posterior receive coils built into the patient table to quantify muscle fat 
fraction. The middle of the slice stack was positioned at the thickest part of the calf, to 
ensure accurate co-localization with the 31P dataset. 
Finally, four HC subjects were scanned twice on the same day with the same imaging 
protocol and settings as described above for the 31P 2D-CSI datasets. Subjects 
were repositioned in the scanner, as accurately as possible, in between the two 
measurements and the survey and T1w sequence were used as reference to plan the 
2D-CSI. CSI datasets were acquired as dynamic scans and retrospectively averaged 
to obtain datasets with 1 signal average for low SNR and one with 12 signal averages 




All phosphorous datasets were visualized with 3D chemical shift image package 
(3DCSi). Individual spectra were identified for six lower leg muscles: the lateral and 
medial head of the gastrocnemius (GCL and GCM), the peroneus (PER), the soleus 
(SOL), the tibialis anterior (TA) and tibialis posterior (TP) muscle, and exported as 
free induction decays. The FIDs were processed in the time domain using AMARES 
in the JMRUI software package (version 5, http://sermn02.uab.es/mrui/). 20 All 
metabolite signals were fitted with Gaussian line shapes, presented as a ratio over 
values.21
22 The shift in resonance between the Pi peak and PCr peak was used to calculate 
the intracellular tissue pH (pH=6.75+log((3.27-S)/(S-5.69))). 23 Since muscles become 
progressively replaced by fat in DMD, several spectra in the DMD patients suffered 
from low SNR. SNR values were determined for each individual spectrum and noise 
was calculated as the standard deviation of the residual signal after fitting. Spectra 
with a SNR lower than 10:1 for PCr and the inability to identify all metabolite signals 
were excluded. 
Datasets from the four healthy volunteers were used to calculate the CV and CR to 
assess the repeatability and accuracy of quantifying PDE-levels between the two 
repeated measurements in high SNR (HH) condition, low SNR (LL) condition, and 
between the high and low SNR condition of the first scan (HL): this latter comparison 
is to mimic the loss in SNR over time due to increased fatty infiltration. The CV was 
calculated by dividing the standard deviation of the repeated measures by the 
mean of the repeated measures. In addition, a Bland-Altman plot was computed 
to show the CR, which is defined as 1.96 times the standard deviation of the paired 
differences, for the same conditions (HH, LL and HL) as the CV values. The mean 
within-subject CV values and CR values are reported for all three conditions. In 
addition, PDE-levels were quantified from spectra acquired in the TA muscle of a 
single healthy subject with different number of averages (NSA= 1, 2, 3, 4, 6 and 12), 
resulting in varying SNR. Results were plotted as a function of the SNR of the PCr 
peak. The voxel was placed partly outside the leg in order to reach sufficiently low 
SNR. Similar analysis for other muscles was not feasible in practice because of the 
intrinsically higher SNR and the inability to place the voxel partly outside the leg. 
The 95% confidence interval of the plateau of the exponential fit was assessed to 
determine a SNR cut-off.
Fat and water images were reconstructed from 3-point Dixon images according to 
a six-peak fat model and used to calculate muscle fat fractions (SI) fat/(SI fat+ SI 
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water))*. 100 (Hu et al 2008) The protocol was optimized to minimize T1 relaxation 
effects. The reconstruction did not account for T2* relaxation times. Regions of 
interest (ROI) were manually drawn for the six individual lower leg muscles on all the 
slices within the coverage of the 2D-CSI using Medical Image Processing Analysis 
and Visualization (MIPAV) software (http://mipav.cit.nih.gov). %Fat is presented 
as the mean value of all pixels within a ROI over multiple slices covering the same 
region as the 2D CSI. 
Statistical Analysis
For the reproducibility assessment in healthy volunteers, a Spearman correlation 
was used to show the between-measurement reproducibility of PDE-levels for the 
three SNR comparisons. Subsequently, a Bland-Altman plot was used to assess the 
agreement between the two repeated measurements for HH, LL, HL conditions. 
For the primary analysis, differences in PDE-levels and %fat between healthy 
controls and DMD patients at baseline, 12-month follow-up and 24-month follow-up 
were assessed with a Mann-Whitney U test with correction for multiple comparisons 
(p<0.001). Thereafter, a Friedman test was used to assess differences in PDE-levels 
and %fat in DMD patients between the subsequent time-points. Here, the level of 
significance was set at p<0.01. 
Post-hoc analyses were done to determine the relationship between PDE-levels and 
age in the TP muscle in DMD patients at baseline, using a Spearman correlation and 
for the difference in Pi, PCr, ATP and intracellular pH between patients and controls, 
as well as for the patients over time. We focused the analysis on the TP muscle as 
it was the only muscle which did not show differences in PDE-levels and %fat at 
baseline. The between-group analyses were done with a Mann-Whitney U test, 
and within the DMD group over time with a Friedman test (p<0.05). All statistical 
analyses were performed in SPSS version 20 for Windows (SPSS Inc., Chicago) 
Results
Phosphorous MR spectra and reconstructed water maps for a representative DMD 
patient for all three time points are shown in Figure 1. All spectra reached the quality 
control criteria for the healthy controls at baseline, five out of 60 spectra were 
excluded at 12-month follow-up and all spectra reached quality control at 24-month 
follow-up. For the DMD subjects 19 out of 108 spectra had to be excluded at baseline, 
11 out of 90 at 12-month follow-up, and 4 out of 72 at 24-month follow-up. All of the 
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spectra of the HC datasets obtained for the reproducibility assessment reached the 
quality control criteria. 
Figure 1. Representative reconstructed water images of the right lower leg and phosphorous spectra 
of the TP muscle of a DMD patient at baseline, 12-months and 24-months. PDE-levels in TP muscles 
are presented in the graph and %fat for the all analyzed muscle for all three time points are stated 
here: (Baseline GCL:5.6%;GCM:7.3%; SOL: 7.1%; PER:14,4%; TA: 6.24%; TP: 4.2%; 12-months: GCL: 
6,6%; GCM:8.8%; SOL: 5.2%; PER:20.6%; TA: 5.71%; TP: 4.3%; 24-months: GCL:10.1%; GCM:11.3% 
SOL: 5.9%; PER:24.7%; TA: 7.3%; TP: 4.3%)
Repeated measures and effect of SNR
To simulate intermediate fat infiltrated muscles, we generated low SNR datasets 
(NSA=1, SNR=15.2±4.1), and compared them to high SNR datasets (NSA=12, 
SNR=22.1 ±0.7). Quantification of PDE-levels proved to be highly reproducible in 
all three conditions with a mean within-subject CV of 4.3% (range:0.29-19%) in 
the HH condition (mean SNR: 22.1; range: 20.8-23.1), a mean within-subject CV of 
5.7% (range:0.03-17.5%) in the LL condition (mean SNR: 15.2; range: 7.5-21.3), and 
a mean within-subject CV of 7.3% (range:0.73-26.3% ) in the HL condition. This high 
reproducibility was also confirmed by intra-class correlation coefficients of 0.98 for 
the HH condition, 0.97 in LL condition and 0.93 in HL condition and good agreement 
in the Bland Altman plots. (Figure 4) In addition, we found that PDE-levels were 
overestimated at lower SNR levels of the PCr peak in the TA muscle (Figure 5). Based 
on the exponential fit, it seems that PDE-levels can be quantified within 95% of the 
confidence interval above SNR levels of 10.4:1 for the PCr peak in the TA muscle. 
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Figure 2.
The black line is the line of identity. 
Figure 3. PDE/ATP as a function of SNR of the PCr peak. Each data point represents PDE/ATP assessed 
plateau. 
%fat and PDE-levels
PDE-levels were significantly elevated compared to healthy controls at all time-
points for all individual leg muscles (p<0.001), with the exception of the TP muscle 
at baseline (p=0.004). No differences were found in PDE-levels between baseline, 
12-month follow-up and 24-month follow-up for the individual muscles (p>0.01). 
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(Figure 2.) However, post-hoc analysis showed a significant positive correlation 
with age in the TP muscle at baseline (R=0.79 p=0.01). This was also the only muscle 
in which fat fraction was not significantly elevated. In addition, %fat significantly 
increased over time for the GCM, GCL, SOL and PER muscle. No differences in 
%fat were detected between time-points for the TA (p =0.061) and the TP muscle 
(p=0.097) (Figure 5). 
Figure 4. Individual trajectories of PDE-levels plotted as a function of age in DMD patients (Red) and 
HC subjects (Black) for the GCL (a), GCM (b), PER (c), SOL (d), TA (e) and TP (f) muscle. The dots with 
groups but did not change over a two-year time period. 
Figure 5. Individual trajectories of fat fraction plotted as a function of age in DMD patients (Red) and 
HC subjects (Black) for the GCL (a), GCM (b), PER (c), SOL (d), TA (e) and TP (f) muscle. The dots with a 
controls in all muscles and all time points with the exception of the TP and TA muscle. 
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Post-hoc analysis for the other metabolic indices
Mean and standard deviation of the metabolic indices in the DMD patients and HC 
subjects at the three time points are shown in Table 1. The individual trajectories 
of the metabolic indices and pH as a function of age in the TP muscle are shown in 
Figure 6. Intracellular tissue pH was significantly elevated compared to controls in 
all analyzed muscles at baseline, 12-month follow-up and 24-month follow-up, with 
the exception of the TP muscle at 12-month and 24-month follow-up. Pi/PCr was 
significantly increased compared to healthy controls in all muscles at baseline, in the 
SOL and PER muscle at 12-month follow-up and in the SOL, PER, TP and GCL muscle 
at 24-month follow-up. In addition, elevated Pi/ATP was found in the SOL and PER 
muscle at baseline, in the SOL and GCM at 12-month follow-up and in all muscles 
except the TA muscle at 24-month follow-up. Finally, PCr/ATP was significantly 
decreased compared to controls in the PER, TP, and TA muscle at baseline. No 
differences were found between groups at the subsequent time points. None of the 
metabolic indices changed over the three time points. However, more pronounced 
changes, although not at a statistically significant level, were visible at 24-month 
follow-up compared to the other time-points.
DMD HC
Baseline 12months 24months Baseline 12months 24months
pH
GCL 7,07±0,04* 7,06±0,04* 7,06±0,02** 7,03±0,03 7,02±0,02 7,01±0,01
GCM 7,07±0,04* 7,07± 0,05* 7,08±0,04** 7,03±0,03 7,02±0,02 7,01±0,02
PER 7,06±0,03** 7,05±0,04* 7,05±0,03** 7,01±0,02 7,02±0,03 7,00±0,01
SOL 7,08±0,05* 7,06±0,05* 7,07±0,03** 7,03±0,02 7,02±0,02 7,01±0,01
TA 7,05±0,03** 7,05±0,03* 7,04±0,03** 7,003±0,02 7,001±0,03 6,97±0,02
TP 7,06±0,03** 7,05±0,04 7,05±0,03 7,008±0,02 7,02±0,02 7,01±0,02
Pi/PCr
GCL 0,14±0,05* 0,12 ±0,05 0,11±0,02* 0,11±0,02 0,09±0,02 0,09±0,02
GCM 0,16±0,04* 0,13±0,02 0,13±0,05 0,12±0,03 0,11±0,02 0,11±0,02
PER 0,14±0,03* 0,14±0,02* 0,14±0,04* 0,10±0,03 0,11±0,02 0,09±0,02
SOL 0,14±0,03** 0,13±0,04** 0,13±0,03* 0,10±0,016 0,11±0,02 0,10±0,02
TA 0,15±0,04* 0,13±0,03 0,12±0,02 0,11±0,02 0,12±0,03 0,10±0,02
TP 0,13±0,03* 0,13±0,02 0,14±0,03* 0,09±0,03 0,10±0,02 0,09±0,04
Pi/ATP
GCL 0,43±0,09 0,36±0,11 0,36±0,07* 0,35±0,09 0,30±0,06 0,31±0,06
GCM 0,46±0,08 0,38 ±0,07* 0,44±0,13* 0,4±0,11 0,32±0,06 0,34±0,06
PER 0,43±0,11* 0,39±0,08 0,42±0,09* 0,38±0,07 0,34±0,08 0,30±0,05
SOL 0,46±0,09** 0,37±0,09** 0,42±0,09* 0,35±0,07 0,32±0,06 0,32±0,06
TA 0,43±0,09 0,37±0,06 0,38±0,09 0,38±0,07 0,37±0,12 0,34±0,06




GCL 3,15±07 3,0±0,56 3,37±0,2 3,35±0,33 3,09±0,38 3,3±0,31
GCM 3,22±0,45 2,89±0,44 3,38±0,35 3,47±0,42 2,96±0,37 3,36±0,24
PER 3,13±0,37* 2,82±0,31 3,21±0,41 3,6±0,39 3,18±0,48 3,34±0,26
SOL 3,23±0,4 2,87±0,45 3,28±0,28 3,34±0,39 2,98±0,41 3,4±0,22
TA 2,97±0,38* 2,86±0,3 3,23±0,3 3,56±0,29 3,16±0,36 3,36±0,41
TP 3,02±0,37* 3,09±0,31 2,94±0,27 3,68±0,34 3,27±0,26 3,21±0,47
PDE/ATP
GCL 0,17±0,09# 0,13±0,07# 0,13±0,04# 0,05±0,03 0,05±0,02 0,04±0,02
GCM 0,17±0,09# 0,17±0,09# 0,16±0,07# 0,06±0,03 0,04±0,01 0,06±0,03
PER 0,16±0,08# 0,13±0,06# 0,14±0,04# 0,06±0,03 0,05±0,03 0,06±0,02
SOL 0,17±0,11# 0,15±0,11# 0,14±0,07# 0,06±0,02 0,05±0,01 0,04±0,03
TA 0,14±0,06# 0,12±0,06# 0,14±0,05# 0,06±0,03 0,05±0,02 0,03±0,03
TP 0,14±0,08 0,16±0,06# 0,15±0,11# 0,07±0,03 0,07±0,02 0,05±0,02
Table 1. Mean values ±SD for the Pi/PCr, Pi/ATP, PCr/ATP and intracellular tissue pH in healthy controls 
phosphate, PDE = phosphodiester, PCr = phosphocreatine, ATP=adenosine triphosphate GCL/GCM= 
lateral and medial head gastrocnemius, PER= peroneus, SOL=soleus, TA=anterior tibialis, TP = 
posterior tibialis
Figure 6. Individual trajectories of Pi/PCr (a), pH (b), PI/ATP (c) and PCr/ATP (d) plotted as a function of 
age in DMD patients (Red) and HC subjects (Black) for the TP muscle. The dots with a connecting line 
represent an individual subject. Note the inconsistent changes in PCr/ATP and the more pronounced 
changes above the age of 10 years. 
Table 1. Continued
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In this study, we assessed the accuracy and reproducibility of quantifying PDE-levels 
by using spatially resolved 31P MRS data in low and high SNR conditions in healthy 
volunteers. Our data proved that quantification of PDE-levels is highly reproducible 
between measurements in both the HL, LL and HH conditions, which is reflected 
by low CV values, high intra-class correlations, and good levels of agreement. As 
the number of studies assessing the reproducibility of resting energy metabolites 
in muscle is limited, comparison to literature values is challenging.  However, 
they are in line with the reproducibility values of different metabolic markers and 
exchange rate constants using dynamic 31P MRS in healthy controls, where CV values 
ranged between 8-11% for phosphate concentrations, between 4 and 12% for PCr 
recovery and between 3.4 and 20% for exchange rate constants of PCr-to-ATP 24-
26. Generally, CV values of 10% or less are considered to be an acceptable level of 
agreement between measurements 27. Previous studies assessed the reproducibility 
of %fat, cross-sectional area (CSA) and water T2 measurements, commonly used 
MR imaging measures in DMD, in both HC subjects and DMD patients within and 
between centers. CV values ranging from 0.8-8% were reported within centers 
with a mean CV of 4.9%, 3.1% and 3.7% for %fat, CSA and T2 relaxation times 28-30. 
CV values of 1.8-7.2% were reported across centers with a mean CV of 7.2, 3.4 
and 1.8 for %fat, CSA and water T2 relaxation times (1H-MRS). 28 The CV values 
found in the present work, for the high, low and high versus low SNR conditions, 
are similar to those of %fat and (water) T2 relaxation times found in literature and 
below the general acceptable level of agreement (<10%). This indicates that even in 
more severely affected patients, simulated by the reduced SNR datasets, one can 
accurately quantify PDE-levels.  However, the question remains whether this would 
be sufficient discriminative power to be able to detect potential treatment effects. 
PDE-levels 
Longitudinal and spatially resolved 31P MRS and qMRI data was used to assess 
the time course of changes in phosphodiester (PDE)-levels over 2-years in DMD 
patients, in muscles with different levels of muscle wasting. Our results showed 
that PDE-levels were significantly elevated in DMD patients compared to controls 
regardless of the level of muscle wasting at virtually all time-points, and did not 
change over a two-year time period. This indicates that, although DMD boys were 
recruited as early as 5.5-year-old, PDE levels were elevated prior to the inclusion of 
the study. The only muscle that did not show abnormal PDE-levels was the TP muscle 
at baseline. Interestingly, this muscle is known to be affected relatively late in the 
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course of the disease, which was confirmed in our data by normal %fat at baseline. 
At later time points, PDE levels became significantly elevated in the TP muscle. This 
suggests that PDE-levels may increase very early in the disease process, after which 
they apparently become more stable. This is in agreement with previous work in 
which PDE-levels of the forearm muscles did not correlate with age in ambulant 
DMD patients and did not show an increase over one year time. 13, 14 This hypothesis 
is also strengthened by our own results in the other muscles which did not show a 
change in PDE-levels over a two-year time period and by the significant correlation 
with age in the TP muscle at baseline. However, previous work also showed that 
PDE-levels did correlate with disease progression in non-ambulant patients as well 
as that PDE-levels showed to be higher in more severely affected patients. 15 Visual 
inspection of our graphs also suggests a non-linear relation between PDE-levels and 
age. Consequently, it is likely that PDE-levels do increase with disease progression 
but much slower than %fat and that a much longer timeframe is needed in order to 
measure this progression. 
PDE-levels in DMD are generally associated with membrane degradation products 
of the preferentially affected glycolytic Type II fibers. 31 However, the precise origin 
of this elevation in PDE is not fully understood. Many other diseases have displayed 
altered intra-cellular PDE-levels in muscle. For instance, in spinal cord injury and 
congenital lipodystrophy, it has been associated with oxidative stress. 32, 33 In obesity 
and diabetes altered PDE-levels have been related to reduced mitochondrial 
capacity. 34 After statin use, in fibromyalgia, Becker muscular dystrophy and 
facioscapulohumeral muscular dystrophy (FSHD), these alterations have been 
ascribed to abnormal membrane metabolism associated with muscle dysfunction. 
11, 22, 35 In addition, PDE-levels have been shown to be related to a higher content 
of oxidative type I fibers, to reflect impaired oxidative muscle metabolism, and 
to increase with respect to age, physical activity level and BMI. 36-38 The total PDE 
signal measured with 31P MRS originates from glycerol 3-phosphocholine (GPC) 
and glycerol 3-phosphoethanolamine (GPE), which are both related to membrane 
phospholipid metabolism. 12, 39-41 Recent work showed that GPC, rather than a 
combination of GPE and GPC, was the main contributor to the changes observed in 
muscular PDE-levels in obesity and diabetes.25 GPC has been shown to accumulate 
due to inhibition of oxidative phosphorylation, which strengthens the relationship 
with impaired oxidative capacity. 42 Unfortunately, the SNR of our data was too low 
to ascribe the changes found in myocellular PDE to either GPC or GPE.  Although, 
the exact underlying cause for the elevation in PDE remains unclear and might be 
multifactorial, this work points out that myocellular PDE-levels detected with 31P 
MRS are extremely interesting in DMD
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Longitudinal evaluation of the other metabolic indices
The majority of the results from the between-group analysis at the three different 
time-points were in agreement with prior cross-sectional work and have been 
discussed previously. 10, 15, 43-46 The longitudinal analysis showed that none of the 
metabolic indices differed between the subsequent time points, which suggests that 
all metabolic alterations remain stable over a two-year time period. These findings 
are in agreement with a one year follow-up study in the forearm muscles of DMD 
patients.14 In contrast, the majority of the previous cross-sectional 31P MRS studies 
in more severely affected DMD patients, did show more pronounced metabolic 
alterations. 10, 15, 44, 45 Similar behavior was visible above the age of 10 in our data, 
although not reaching statistical significance. Therefore, our results and those of 
others together suggest that the metabolic indices most likely show a very slow 
potentially non-linear progression over time after the initial increase. Even though 
none of the metabolic indices changed over the two-year time period in our study, 
those metabolic alterations do reflect status of muscle tissue and could therefore 
provide important insights into the underlying pathophysiology. 
Limitations
Some limitations of the study should be acknowledged. Firstly, some of the MR 
spectra had to be discarded due to insufficient quality. This could have resulted in 
some bias towards less severely affected muscles and could possibly explain that 
no significant abnormalities were found in PCr/ATP ratios. Secondly, the number of 
patients in the DMD group at 24-month follow-up was relatively low compared to the 
other time-points. The DMD patients who were unable to participate at 24-month 
follow-up were generally of older age. Therefore, the results could be biased towards 
less severely affected muscles and this might have resulted in smaller differences in 
metabolic indices over the time-points. However, all patients were able to participate 
in the 12-month follow-up and no changes were detected between baseline and 
12-month follow-up. Therefore it seems unlikely that this had a major influence on 
our results.  Thirdly, as the diameter of the muscles changes along the length of 
the lower leg, it is somewhat difficult to position an individual voxel of the 2D-CSI 
within an individual muscle over the full length of the coil. The T1-weighted images, 
obtained as anatomical reference, were carefully used in order to ensure that one 
individual voxel was located within one individual muscle over the full length of 
the coil in order to minimize this problem. Fourthly, the fact that DMD boys and 
HC boys inevitably grow during a 2-year longitudinal study complicates accurate 
repositioning between subsequent time-points. To circumvent this problem, the 
T1-weighted images from the previous time-point were used as a visual reference 
to ensure that 2D-CSI was located at a similar position along the proximo-distal 
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muscle axis. However, the fact that the size of the leg could have increased between 
the subsequent time points makes it impossible to cover the exact same region. In 
addition, the SNR of the 31P MRS datasets in this work was insufficient to separate 
GPC and GPE. Previous work showed that, in order to reach sufficient SNR, surface 
coil localized measurements are necessary. However, with those measurements it 
is impossible to obtain muscle specific measurements, which is essential in DMD as 
muscles become affected at different time points and with different rates.  Lastly, 
the relation between SNR and quantification of PDE-levels was only assessed for 
the TA muscle and in one of the subjects. Therefore, it is possible that this relation is 
different in the other lower leg muscles. However, this is highly unlikely as accuracy 
of quantification depends on data-quality and not muscle-type. 
Conclusion
The two-fold elevation in PDE-levels compared to controls detected prior to 
structural changes and the high reproducibility of the measurements in low and high 
SNR conditions confirm the potential of PDE as a marker for muscle tissue changes 
in DMD patients.
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Figure 1. Example of the planning of the 31P 2D-CSI dataset superimposed on an axial T1-weighted 
lower-leg muscle over the entire length of the coil: shown for the most distal, middle  and proximal 
slice of the T1-weighted image. 
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Fast Multi-Station Water/Fat Imaging at 
3T using DREAM-based RF Shimming
M.T. Hooijmans, O. Dzyubachyk, K. Nehrke, P. Koken, M.J.Versluis, H.E. Kan, 
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Purpose: To show the effect, efficiency and image quality improvements achievable 
by Dual Refocusing Echo Acquisition Mode (DREAM)-based  shimming in whole-
body MRI at 3T using the example of water/fat imaging. 
Materials and methods: 3D multi-station, dual-echo mDixon Gradient Echo 
imaging was performed in 10 healthy subjects on a clinical 3T dual-transmit MRI 
system using station-to-station adapted  shimming based on fast DREAM  
mapping. Whole-body data were obtained using conventional quadrature excitation 
and station-by-station adapted DREAM-based  shimmed excitation, along with 
the corresponding  maps for both excitation modes to assess image quality and 
RF performance. 
Results: Station-dependent DREAM-based  shimming showed significantly 
improved image quality in the stations covering the upper legs, pelvis and upper 
body region for all subjects (p< 0.02). This finding is supported by corresponding  
maps showing an improved  homogeneity and a more precise nominal flip angle 
in the DREAM-based  shimmed excitation (p<0.01). Furthermore, the very short 
dual-channel DREAM  mapping times of less than 2 seconds facilitate quick  
shimming. 
Conclusion: Station-dependent DREAM-based  shimming improved RF 
performance and image quality and is therefore a promising technique for whole-
body multi-station imaging applications. 
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INTRODUCTION
Whole-body magnetic resonance imaging (WB-MRI) applications are receiving 
more clinical attention. 1, 2In clinical practice, many of these whole-body scans are 
acquired at moderate field strengths (1.5T) attributable to the sufficient image 
quality acquired in reasonable measuring times. 3, 4 However, due to the gain in 
signal-to-noise ratio (SNR) that can be traded into increased spatial resolution 
or scan acceleration, WB-MRI at higher field strength, like 3T, is becoming more 
popular. However, at these higher field strengths the effective wavelength of the 
RF transmit field ( ) inside the patient can approach body dimensions, resulting in 
standing wave-kind effects, which affects the RF-field homogeneity. This can cause 
spatially varying image contrast and SNR, which may have serious effects on the 
quality of clinical diagnosis. 5
Several approaches have been suggested to address this problem. 3, 5-7 One of the 
most effective emerging options is dual-channel parallel transmission that allows 
mitigating this problem by an enhanced control of the RF-field for each individual 
transmit channel. This allows /RF shimming in a subject-specific way, adjusting 
the relative  amplitudes and phases of the otherwise identical waveforms in each 
of the transmit channels to significantly improve  uniformity. 5, 8, 9 However, a 
prerequisite for patient specific RF shimming is the knowledge about the underlying 
channel-specific  maps that have to be measured with the patient in place. Most 
current  mapping approaches are rather time-consuming, requiring a time-period 
of at least 15 s for mapping without acquiring any diagnostic data.10-13 Therefore, 
especially in multi-station whole-body imaging where the RF-field can change 
continuously from station to station, very fast and appropriate  mapping is required 
to facilitate adaptive RF shimming. Recently, a new approach for  mapping, Dual 
Refocusing Echo Acquisition Mode (DREAM), which allows single shot  mapping 
within a fraction of a second, was introduced. 14 Based on the quickly acquired 
 maps for the individual transmit channels involved, appropriate and fast  
shimming can be performed for each individual station during multi-station imaging 
with the potential to meet the needs for the clinical practice. Therefore, the purpose 
of this study is to evaluate the effect, efficiency and image quality improvements 
achievable with DREAM-based  shimming in whole-body MRI at a clinical dual-





Ten healthy subjects (eight male/two female) participated in the study, age: 
36.2±8.3 (range: 24–45 years), BMI: 24.25±3.1 kg/m2 (range: 20.6–29.2 kg/m2), body 
size: 1.81±0.09 m (range 1.65–1.92 m), and mass: 80.1±15.4 kg (range: 56–100 kg). 
The experiments were approved by the local institutional Ethics Committees, and 
all participants gave written informed consent before their enrolment in the study. 
Five of the participating subjects were studied at Philips Research Laboratories, 
Hamburg and five at Leiden University Medical Center, recruited from the LUMC 
radiology database. 
MR technique
Whole-body multi-station data sets were acquired using clinical 3T dual-transmit 
MRI systems (Ingenia, Philips, Healthcare, Best, the Netherlands). The body coil was 
used for reception and the subjects were positioned head first in supine position. 
An identical MRI protocol was used in both centres, starting the data acquisition 
for each station with a 2D  DREAM  calibration scan, which is actually a  
mapping scan for both transmit channels (Figure 1). 14 DREAM is a magnetization 
prepared single shot sequence. It employs a STEAM preparation module for B1
+ 
encoding and a low-angle pulse train to read-out the thus prepared magnetization, 
acquiring the stimulated echo (STE) and the free-induction decay (FID) signal almost 
simultaneously on the same readout, as gradient recalled echoes separated in time 
with appropriate gradient encoding. The true flip angle / B1
+ map is derived from the 
ratio between the STE and FID signal, while the phase is derived from the relative 
transmit phase, directly adopted from one of the source images. In the present 
work the, the “STE first” DREAM sequence version was used The DREAM scan 
was centred in the middle of each station to optimize  shimming performance. 
DREAM parameters: field-of-view (FoV): 450×450 mm², voxel size: 7×7×15 mm3, 
FID/TESTE/TR: 1.06/2.3/3.8 ms, shot duration: 150 ms. 
This dual-channel DREAM  mapping took roughly 1.3 s per station without the 
use of breath holds, including a waiting time of 1 s between left and right channel 
transmission. The  maps were handed over to the system’s RF shim algorithm for 
estimation of the optimal RF amplitude gains per channel, denoted by their ratio 
(dBratio) and phase offsets ( ) while ensuring the SAR limits with the patient 
in place. Subsequently to the  calibration scan,  maps were obtained for the 
conventional quadrature transmit mode and the  DREAM-shimmed transmit mode 
with similar sequence parameters as mentioned above facilitating the comparison 
of dual-channel shimming performance. By “quadrature” we refer to the circular 
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transmit mode of the unloaded coil (equal amplitudes and fixed 90  phase offset 
for the two RF channels). Next, two multi-station 3D dual-echo mDixon Gradient 
Echo acquisitions were measured with the following scan parameters: 24 contiguous 
axial slices, TR/TE1/TE2: 3.2/1.13/2.0 ms, FA: 5 , FoV: 520×359×120 mm3, voxel size: 
1.91 1.91 5 mm³, one with DREAM-based  shim sets and the other in quadrature 
mode. 15 Water/fat separation was performed as the final step after single-echo 
image reconstruction yielding 3D in-phase (IP), out-of-phase (OP), water, and fat 
images. The entire acquisition block, comprising 2D  DREAM mapping and 3D 
water/fat resolved scanning (Fig. 1), is embedded in a multi-station acquisition using 
16–18 stations with 10 mm station overlap. Breath-holds with duration of 19 s were 
solely performed for the stations covering the pelvis and chest region. The entire 
whole-body protocol was performed in a single run starting at the feet and had a 
total duration of approximately 20 minutes.
Figure 1. Illustration of the multi-station MR protocol used in this study. For each station, a set of 
scans was performed starting with a DREAM calibration scan followed by  shim calculation. 
Subsequently, two DREAM maps were acquired to map the conventional quadrature mode RF-
-shimmed one, respectively. Finally, two 3D mDixon Gradient Echo 
scans were performed in both excitation modes. After this acquisition, the systems proceeds to the 
next station repeating this procedure to acquire the data for the whole multi-station protocol in one 
run, starting in the feet. 
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Image and data analysis
Image quality of the two 3D whole-body water/fat resolved scans acquired with the 
different excitation modes, was independently scored by three MR readers with 
at least 10 years’ experience (MV, HK, KN) without knowledge of the  shimming 
condition during image acquisition using one representative IP slice from five 
individual stations covering the lower leg (station 3/4), upper leg (station 6/7), 
pelvis (station 9/10), abdomen (station 12/13) and head (station 15/16/17) region. 
Scoring was performed solely on image quality using an adjusted five-point grading 
system [accordingly 1 (very bad) to 5 (excellent)], disregarding the part about their 
diagnostic value. 5 In addition to this subjective measure, a more objective image 
quality measure was defined using the entropy  of the normalized image intensity 
histogram : .  16 More precisely, the ratio between the 
histogram entropy  for RF shimmed and  for quadrature mode data 
has been used for each individual station and all image types. Values below unity 
indicate improved image quality on the -shimmed volumes and vice versa. Two 
additional quality measures characterizing the RF field, the coefficient of variation 
CV, defined as the ratio between the standard deviation  and the mean of the non-
noise values in the  map, : , and the , were determined 
for each individual station for the   maps acquired in the different excitation 
modes. 16 Furthermore, the DREAM-based  shim settings, the transmit channel 
amplitude ratio (dBratio) and the phase offset ( ), were recorded for all stations and 
volunteers. To assess the overall  shim performance, the CV, , , and dBratio 
were averaged over all subjects and compared for each individual station. This 
required prior alignment of all the data sets as the subject height varied considerably, 
resulting in different numbers of stations required to cover the complete body of 
the individual volunteers. Alignment was achieved by selecting 15 stations that were 
represented in all the subjects. This, in particular, required disregarding the station 
covering the feet in all the subjects and additional removal of one station covering 
the upper thigh region in two of them.
Statistical analysis 
The inter-observer agreement was determined with the Kendall  coefficient; 
values higher than 0.7 were considered to indicate excellent agreement. In the case 
of excellent inter-observer agreement, the data was pooled for all the observers and 
the average scores were reported. The Wilcoxon signed-rank test has been used 
to determine the difference in image quality between the two excitation modes 
assessed with image grading. After alignment of the data sets, a paired-sample 
t-test was used to assess the difference in mean values for the CV and  values 
for the different excitation modes. After grouping of the individual stations of all 
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subjects in five zones, classified as: the head, abdomen/chest, pelvis, upper leg and 
lower leg, the Kolmogorov-Smirnov test was used to test significance of the changes 
in CV and  The  significance level was set at p<0.05. All statistical analysis was 
performed using SPSS version 20 for Windows (SPSS Inc., Chicago).
RESULTS
All volunteer scans performed at the two different sites were successfully performed.
Image quality
The comparison of the whole-body data sets obtained with both RF excitation modes 
revealed a consistent improvement in image quality for all subjects in the images 
acquired with DREAM-based  shimmed excitation (Figs. 2,3). The scoring of the 
Figure 2. Coronal reformat of the entire reconstructed whole-body volumes. One coronal slice is shown 
from the gradient echo mDixon images of a representative subject, obtained in the conventional 
quadrature mode: (a) in-phase, (b) water only; and using DREAM-based -shimmed mode: (c) in-
based  shimmed case compared to the conventional quadrature situation is visible in the stations 
covering the torso and upper legs. The images were not further corrected for the remaining stitching 
artefacts; those are kept on purpose to illustrate the multi-station nature of the data. 
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images showed significant improvements in the stations covering the upper leg, 
pelvis and upper body region (p=0.014, p<0.0001, p<0.0001), while no improvement 
in image quality was visible in the stations covering the lower leg and head region 
(p=0.28, p=0.99) (Table 1). Excellent inter-observer agreement (Kendall =0.705–
0.771, p<0.01) was found between observers’ grading of the images. These observer-
perception-driven results were supported by the image histogram entropy ratio 
values of both the IP/OP and fat/water images that confirm the improvement in 
Figure 3. Axial in-phase images and corresponding  maps for the two excitation modes. Gradient 
echo mDixon in-phase images of a representative subject are shown for various stations in (a) for 
quadrature and (b) for DREAM-based -shimmed excitation, along with corresponding DREAM  
maps: (c) for quadrature and (d) for the -shimmed case, respectively. Most pronounced changes 
consisting of less spatially varying image contrast and RF shading are visible in the upper body region. 
The stations marked with the arrows (left) are used for the visual grading of the image quality in this 
particular example; see also Table 1. 
115
Multi-station DREAM based RF shimming in Whole Body Imaging
6
image quality (Figures 4b,c). This is especially obvious in the upper body region 
together with less conclusive results in the head and lower leg region compared to 
the human observers. In addition, a more obvious effect in image histogram entropy 
was visible in the water images compared to the fat images (Figures 4b,c).
Figure 4. Summarised multi-station results 
averaged over the entire cohort. (a) Shows 
the anatomical location of each station. 
Data have been resampled to 15 stations, 
with station 1 corresponding to the head and 
station 15 representing the feet. The average 
ratio between the histogram entropy for the 
RF shimmed and quadrature mode excitations 
were calculated for IP/OP and water/fat mDixon 
images: (b) Shows the average histogram 
entropy ratios per individual station for the IP, 
the OP and both image types together (joint). 
Values below unity indicate improved image 
quality for the RF shimmed data. (c) Shows 
the histogram entropy ratios for the water-
only, fat-only data and both image types 
together (joint), with the water-only showing 
homogeneity. (d,e) Compare the measured 
DREAM  maps in quadrature (“Quad”) and 
DREAM-based shimmed (“Shim”) excitation 
(CV) for both excitation modes, illustrating an 
improvement in RF homogeneity for DREAM-
indicates a better homogeneity. (e) Shows 
the mean , normalised to the desired/
expected value (given in %) for both modes, 
demonstrating the better performance for 
the RF shimmed case. The station-dependent 
RF shim values (f,g) show considerable 
 (given 
in degree) and in (g) the amplitude ratio of the 
two channels (measured in dB) are shown. 
standard deviation, whereas the dashed lines 
represent the minimum and maximum values 
of the corresponding variable. 
116
Chapter 6
     maps
The evaluation of the  maps to asses overall shimming performance in both 
excitation modes showed an improvement in the homogeneity of the transmit RF-
the CV compared to the conventional quadrature excitation: quadrature=0.20±0.03, 
shimmed=0.14±0.02, p<0.001 (Figs. 3,4d). This reduction is mainly found in the upper 
legs, pelvis and abdomen; see Table 1. In addition to the increase in  homogeneity, 
a more accurate  level was obtained with DREAM-based  shimming: 
quadrature=79±4 %, shimmed=92±4 %, p<0.001; (Fig. 4e). Similar improvements were 
 
shim sets (dBratio, ) varied continuously throughout the stations, which is shown in 
Figs. 4f,g. Most pronounced changes of the shim settings were visible in the stations 
acquired in the shoulder-neck region, the pelvis and upper legs.
DISCUSSION
This study aimed at evaluating the effect, efficiency, and image quality improvements 
achievable using DREAM-based  shimming to mitigate wave-propagation effects 
in whole-body imaging at 3T. Compared to conventional quadrature excitation, 
significant and consistent improvements in  homogeneity and image quality 
are shown for multi-station water/fat imaging according to DREAM-based  
shimming per station. These improvements were obvious in stations covering the 
Excitation mode Head Abdomen / chest Pelvis Upper leg Lower leg
Image quality Quad 4.9±0.16 2.2±0.5 2.7±0.47 3.4±0.21 3.6±0.43
DREAM-based RF 
shimmed 
4.9±0.16 4.3±0.43* 4.3±0.43* 3.7±0.27* 3.7±0.44
CV Quad 0.11±0.03 0.26±0.04 0.23±0.03 0.18±0.01 0.16±0.03
DREAM-based RF 
shimmed
0.10±0.02 0.15±0.03* 0.12±0.02* 0.16±0.02* 0.15±0.03
, (%)
Quad 87.1±2.4 70.5±5.1 74.4±6.0 85.8±1.7 85.5±1.4
DREAM-based RF 
shimmed
98.1±1.9* 87.9±5.2* 93.5±3.1* 93.8±3.0* 89.9±4.4*
Table 1. Overview of the results. The mean and standard deviation for image quality according to 
image grading [score accordingly 1 (very bad) to 5 (excellent)], the CV, and the  for DREAM-based 
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region from the upper body to the upper legs and were consistently confirmed by 
three independent measures: visual subjective grading, objective evaluation of the 
entropy of the image histogram and reduced coefficient of variation and better 
nominal flip angle derived from the RF shimmed  maps. Histogram entropy ratios 
were measured for the IP/OP and the water/fat volumes. For the IP/OP images, all 
three plots (including the joint entropy ratio estimation) clearly show improved and 
similar behaviour achieved due to RF shimming. However, the improvements for 
the water images are more obvious compared to the fat. This could be due to two 
reasons. First of all, fat does not show significant wave propagation effects at 3T, 
whereas water does. 17, 18 Having both separated can make this effect more obvious. 
Second, water-rich tissue is located in the body core, where wave propagation 
effects predominantly occur, whereas fat is often more present in the periphery and 
thus less affected by the field inhomogeneity.
Nevertheless, no significant improvements in image quality and RF homogeneity 
were found in stations covering the lower leg and head region, which suggests some 
station dependency in the effectiveness of RF shimming. This fact is not surprising, 
as  the effective wavelength at 3T might not approach object dimensions in the 
lower legs and the head, in contradistinction to other parts of the body. However, 
also in those regions were no improvement in image quality and RF homogeneity 
was found, as well as in all the other regions in general, a more precise flip angle was 
measured after applying  shimming. This indicates that the flip angle necessary 
to generate the correct image contrast during acquisition, is better maintained as a 
result of the applied  shimming procedure per station.
It is furthermore interesting to review some of the station-dependent RF shim 
settings. Significant changes in the RF shim settings (dBratio, ) with respect 
to quadrature mode were visible in both the shoulder/neck and leg region for all 
subjects. This could be explained by the asymmetrical loading of the body coil in 
the feed-head direction, emphasising the need for station-specific adjustments of 
the RF-field. Nevertheless, within consecutive stations covering the upper body 
region, less variation in the optimized  shim settings was revealed, although quite 
substantial fluctuation between thorax and abdomen was found in some individuals. 
Hence, we question if region- instead of station-specific RF shimming could be 
sufficient for such multi-station whole-body applications. However, given that 
already small changes to the driving conditions of the channels can have impact on 
the RF performance, together with the major improvement shown in the mapping 
efficiency using DREAM, one could suggest that station-specific RF shimming could 
be recommended just as precaution. 
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The improvements shown with DREAM-based dual-channel RF shimming shown 
in this work are in line with findings of several other investigators applying RF 
shimming methods in the abdomen or other anatomical regions at 3T. 7, 19 However, 
the greatest benefit of this recently introduced DREAM  mapping method is the 
time-efficiency, accelerating dual-channel  mapping for RF shimming by an order 
of magnitude compared to other, rather time-consuming,  mapping approaches. 
10, 20 This allows RF transmit performance to be optimized per station during multi-
station imaging applications without significant loss of scan efficiency regarding the 
acquisition of the desired diagnostic data. Furthermore, DREAM has the potential 
to be applied during very shallow or free breathing in comparison to other methods, 
where at least 15 seconds breath-holds are necessary to make proper adjustments 
to the RF-field. Apart from the gain in efficiency, this also eases system workflow, 
because the operator does not need to instruct the patient about potential breath-
holding constraints. 
One potential limitation of this study is that it solely compares DREAM-based  
shimming with the conventional quadrature excitation instead of comparing it to other 
RF shimming approaches. 21 However, the performance of RF shimming depending on 
the employed  calibration has been recently studied by comparing DREAM to two 
other  mapping approaches at a clinical dual-channel 3T MR system.21 It was found 
that the RF shim results achieved with DREAM-based RF shimming were equivalent 
to those currently achieved with the other RF shimming methods in healthy controls. 
This implies that the positive effects with DREAM-based RF shimming shown in this 
study do not overestimate the effectiveness of this method. Secondly, only a small 
number of subjects participated in the study. As an improvement in image quality, 
flip angle accuracy and  homogeneity due to RF shimming is not unexpected, it 
might has influenced some of the minor, non-significant findings in the lower leg 
region. The whole-body application used in this study is focussed on water/fat 
resolved volumetric imaging. This is of great importance in obesity-related research, 
where the amount and distribution of body fat are important diagnostic parameters, 
as well as in other systemic diseases, where the water fat distribution throughout 
the body is of interest. 22, 23 However, it is important to note that the effective multi-
station DREAM  mapping and shimming approach can easily be generalized to 
other whole-body imaging applications addressing different MR contrasts. Thereby 
this DREAM-based RF shimming approach could be even more beneficial in whole 
body imaging applications based on the more  sensitive Spin Echo or fast Spin-
Echo sequences or in imaging techniques where precise magnetization preparation 
is crucial as in fat suppression for example.
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In conclusion, DREAM-based multi-station  shimming showed to be very fast and 
effective compared to standard approaches currently available. Thereby, it achieves 
the desired improvements in transmit RF-field homogeneity, flip angle accuracy, 
image quality and workflow, suggesting that DREAM  mapping could be of 
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The overall aim of this thesis was to combine various quantitative MR measurements 
and compare these combined measurements between DMD patients and healthy 
age-matched controls both on a cross-sectional and longitudinal level, in order 
to generate a better understanding of the underlying pathophysiology of the 
disease and ideally to determine the potential of these MRI outcome parameters 
for monitoring muscle tissue changes in a clinical setting. In order to achieve this 
aim, we assessed the effect of spatial localization, data quality and confounding 
effects on the quantification process for various MR outcome parameters. We used 
a combination of quantitative MRI and spatially resolved 31P MRS to contribute to 
the understanding of the pathophysiology in DMD. 
In chapter 2 we explored the effect of %fat, SNR and T2 relaxation time changes 
on quantitative DTI measurements in skeletal muscle of DMD patients. We showed 
that sufficient SNR is essential for a reliable estimation of the DTI parameters, 
and that in vivo measurements of % fat and mean water T2 are necessary to assess 
whether detected changes in DTI parameters could be ascribed to pathophysiology 
or to confounding effects related to low SNR. Overall, we showed that reliable DTI 
measurements in skeletal muscle can be obtained in DMD patients and healthy 
controls, if confounding factors are accounted for. 
In chapter 3 we studied fat replacement along the proximodistal muscle axis in 
DMD patients by using the Dixon technique. We showed that muscle fat fractions 
were non-uniformly distributed along the proximodistal muscle axis, with higher 
fat fractions in the muscle end-regions compared to the muscle belly. In addition, 
we showed the importance of accurate spatial localization along the proximodistal 
muscle axis when quantifying muscle fat fractions. A slight shift of the slice stack 
along the proximodistal muscle axis resulted in a difference in mean fat fraction 
which was on average 1-2%, but with values measured up to 12%. This non-uniformity 
in fat fraction within an individual muscle has a major influence on quantitative MR 
measurements that are currently being considered as outcome measures in clinical 
trials, and highlights the need for accurate repositioning in longitudinal MR studies. 
In addition, these findings pointed to mechanical disruption of the membrane as one 
of the key factors in the pathophysiology of DMD. 
Chapter 4 presented a combination of quantitative MRI and spatially-resolved 
(2D-CSI) 31P MRS data in the leg muscles of DMD patients to determine metabolic 
changes and inflammation in muscles with and without fat infiltration, in order to 
assess if metabolic changes and inflammation vary at different stages of the disease 
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process. Both PDE-levels and water T2 values were significantly increased prior to the 
occurrence of fat infiltration, and remained elevated in muscles with fat infiltration; 
whereas Pi/ATP and intracellular tissue pH only changed in muscles that showed 
fat infiltration. This indicates that we were able to distinguish between early and 
late pathophysiological changes in DMD patients. More specifically, this suggested 
that PDE-levels and water T2 values could not only function as early markers for 
muscle tissue change, but could also reflect potentially reversible pathology in more 
advanced stages of the disease. 
In chapter 5 we assessed the time course of changes in PDE-levels detected by 31P 
MRS and the potential value of PDE-levels to monitor muscle tissue changes in DMD 
patients, using longitudinal and spatially resolved 31P MRS and qMRI data of lower leg 
muscles that display varying levels of muscle wasting. PDE-levels were significantly 
higher (two-fold) compared to controls in all analyzed muscles at almost all time 
points, and did not change over a 2 year time period. Muscle fat fraction significantly 
increased between the subsequent time points in all analyzed muscles of the DMD 
patients. In addition, we also assessed the reproducibility of quantifying PDE-levels 
between two subsequent measurements and the effect of SNR on the accuracy of 
such quantification. We showed that PDE-levels can reliably and reproducibly be 
quantified with 31P 2D-CSI in both high and low SNR data sets. The two-fold increase 
in PDE-levels compared to controls, the stabilization over a two-year time period, 
its detection prior to structural changes, and its high reproducibility in low and high 
SNR data confirm the potential of PDE-levels as a marker to monitor muscle tissue 
changes in DMD patients. 
Chapter 6 evaluated the implementation of a fast DREAM-based B1
+ shimming 
approach in a whole-body fat/water separation application at 3T. Multi-station 
DREAM-based B1
+ shimming showed significantly improved data quality in the 
stations covering the region from the upper leg to upper body compared to a 
conventional single shim approach. These improvements were supported by 
the corresponding B1
+ maps which showed a more precise flip angle and a more 
homogeneous B1
+ field. DREAM-based B1
+ shimming was shown to be very fast 
and effective compared to currently available methods, achieving the desired 
improvements in the transmit RF-field homogeneity, the flip angle accuracy and 
the image quality while accelerating the calibration process by a factor of ten. This 
suggests that DREAM-based B1
+ shimming is a very promising technique for multi-




In this thesis, a wide variety of individual MR techniques have been used to assess 
various pathophysiological changes in healthy and diseased skeletal muscle, on 
both a cross-sectional and longitudinal level. However, instead of only focussing 
on individual techniques, this thesis aimed to combine these techniques in a multi-
parametric MR approach in order to: 1) assess the effects that methodological aspects 
can have on quantification, 2) generate a better understanding of the underlying 
pathophysiology in DMD, and 3) determine the value of these MR outcome parameters 
to monitor muscle tissue changes. (Figure 7.1) In this chapter, the key findings of the 
results will be discussed and put into the context of the existing scientific literature. 
The first part of this chapter will focus on the effect of methodological factors such 
as data quality, spatial localization and confounding factors on quantification in 
skeletal muscle applications. The second part of the discussion will focus on how this 
thesis contributed to new insights in the pathophysiology of DMD, and how these 
insights can form the foundation for future work. 
Figure 1. A schematic overview of the inter-connection of all topics in the discussion. 
Multi-parametric MRI  
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7.2.1 Quantification: Data-quality, Confounders and Spatial localization
In this thesis, 31P 2D CSI and two advanced quantitative imaging techniques have 
been evaluated with regards to data quality, confounding effects and accuracy of 
spatial localization between measurements, in order to assess the effect of these 
factors on quantification of MR outcome parameters and data interpretation. 
7.2.2 Data quality
One of the most common measures used to support a statement about data quality 
in quantitative MRI is the SNR, where high SNR levels are important to ensure good-
quality data. SNR is usually defined as the mean signal divided by the standard 
deviation of the noise. Previous simulation-based studies from other groups have 
shown that the reliability of estimating DTI based parameters in skeletal muscle is 
highly sensitive to changes in SNR, muscle fat fraction and edema/inflammation-
like processes. 1, 2 Chapter 2 of this thesis evaluated the effect of SNR on the DTI 
parameter estimation in an in-vivo situation, and showed that high-quality data was 
a prerequisite for a correct DTI parameter estimation in skeletal muscle. To ensure 
a robust estimation of DTI-based parameters, one could try to fully exclude the 
effect of data quality on quantification, by acquisition of only high SNR data sets. 
This can be generalized by reducing spatial resolution or by averaging of more data 
sets. However, neither “solution” is optimal in a clinical setting, as more averaging 
is inextricably linked with long measurement times, and a lower resolution results 
in reduced specificity of the measurements. Moreover, accurate quantification 
of MR outcome parameters usually involves sufficient levels of SNR rather than 
maximizing SNR. More specifically, this means that above a certain threshold the 
robustness of the estimation is relatively stable. The same holds for our data; all five 
DTI-based parameters (three eigenvalues, MD and FA) can be estimated properly in 
skeletal muscle with SNR levels above 20, while MD itself can already be estimated 
properly with SNR levels above 15. Similar findings have been reported in other 
muscle applications such as STE DTI and BOLD imaging. 3 4 The influence of data-
quality on the quantification process has been evaluated in more detail in chapter 
5 of this thesis by assessing the relation between SNR and PDE-levels and showed 
that above a certain threshold (SNR PCr peak > 10) PDE-levels could reliably be 
quantified. Consequently, our recommendation is that the MR protocol needs to 
be optimized in order to eliminate the effect of SNR on quantification, by reaching 
sufficient levels to ensure a robust estimation of the desired MR outcome parameter, 
rather than being aimed at maximizing data quality which may take an impractical 
amount of scan time. Eventually, it is important that sufficient data quality is 
reached to quantify and interpret the results, while also taking into account the scan 
duration. The optimal situation will vary by technique and by application, but scan 
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durations that exceed 5 minutes are not desirable, especially not in young children 
and patients who may be more prone to scan discomfort.
7.2.3 Confounding factors
Accurate spatial co-localization in a multi-parametric MR approach, when executed 
properly, allows among other things the detection of potential confounding 
factors which can either overshadow pathology or create the impression of 
pathology. Chapter 2 of this thesis evaluated the effect of %fat and water T2 on 
the DTI parameter estimation in an in-vivo situation, and showed that for a robust 
implementation of DTI measurements, additional factors such as water T2 changes 
and %fat need to be measured to prevent unnecessary sources of error when 
interpreting the results. In addition, our work and experimental data of others 
showed that, besides the direct effect that %fat and water T2 changes had on the 
SNR in a SE-EPI sequence, both measures could also act as independent confounders 
on the DTI parameter estimation.1, 2, 5 However, the exact separate effect that these 
confounders had on the DTI parameter estimation was difficult to assess in our in-
vivo approach. This was due to the low inflammation component of the disease and 
the direct inverse relation of %fat with SNR. Future work should aim at acquisition 
of high SNR datasets in more pronounced fatty-infiltrated muscles to evaluate the 
true confounding effect of fat.
The impact of confounding factors has also been shown in other quantitative MR 
techniques of skeletal muscle, for example Quantitative Magnetization Transfer 
(QMT) and BOLD imaging.4 More specifically, both our work and that of others 
showed that the presence of adipose tissue (muscle fat replacement), low SNR data, 
and changes in T2 (fibrosis and inflammatory processes) are common confounding 
factors in MR techniques used in skeletal muscle applications. However, these 
common confounding factors are also considered as inevitable structural changes 
associated with damage, disease and exercise in skeletal muscle. The precise effect 
that these specific confounders have on the measurement is technique-dependent. 
Such technique-specific knowledge is essential in order to be able to ascribe 
detected changes to either pathology or confounding factors, and to ensure accurate 
interpretation of the results. In the end, the feasibility of multi-parametric MRI in 
clinical practice can be questioned, but the impact that accounting for confounding 
factors has on data interpretation is very clear. 
7.2.4 Accuracy of spatial localization between measurements
In skeletal muscle applications, repositioning between measurements is usually 
done by using a combination of bony landmarks, internal muscle references, and 
129
Summary and general discussion
7
external references such as fish oil capsules placed on the skin. 6, 7 Up to now, 
there is very little knowledge about the accuracy of spatial localization between 
measurements based on these guidelines, and more importantly the impact that 
slight imperfections in spatial localization can have on quantitative measures in 
skeletal muscle applications. 
In chapter three of this thesis we showed that slight errors in spatial localization 
caused artificial differences in mean fat fraction which were on average 1-2% 
and ranged up to 12% in DMD patients. This effect is caused by the specific non-
uniform parabolic distribution of fat replacement along the proximodistal muscle 
axis. However, this is not specific for DMD or for fat replacement, as in at least two 
other muscle diseases non-uniform distributions of muscle fat replacement along 
the muscle axis 8, 9 have been reported. Muscle tears and injuries are highly location 
specific and exercise effects are muscle- and location-dependent. Therefore, the 
impact that accuracy of spatial localization can have on quantification is in fact a 
very common problem. 
However, in the end, it is only relevant to know what the impact of these imperfections 
in spatial localization will be on a group level basis. For example, in the case of 
a parabolic distribution, if the slice stack is positioned at the lowest point of the 
parabola, a shift in any direction will result in an artificial increase of the outcome 
parameter which cannot be levelled out on a group level. However, slice stacks or 
volumes are generally located at a specific distance from a bony landmark which 
does not directly match to the lowest point of the parabola in a specific muscle. As 
a result, parameter estimates can be under- or overestimated, and this difference 
could possibly be averaged out on a group level. Ultimately, the effect of these 
imperfections in spatial localization on quantification will be highly dependent on 
the shape of the distribution of tissue changes (e.g. linear curve, U-shaped curve, 
focal lesions, exponential curve) along the length of the muscle. Nevertheless, on a 
group level basis, it will at least affect the discriminative power of the technique to 
detect change.
The effect of these imperfections on spatial localization becomes even more 
complicated in longitudinal study set-ups with pediatric study population and after 
exercise regimes, as muscles will inevitably change between time-points. This 
complicates repositioning according to bony landmarks and internal references. In 
addition, the intrinsic parameters involved in the methodology of most imaging and 
spectroscopy approaches, e.g. slice gaps, slice thickness, field-of-view and restricted 
voxel size, could result in limited and location-specific information. Both these 
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methodological aspects magnify the impact that spatial localization imperfections 
can have on quantitative outcome measures. Therefore it is recommended to 
establish a protocol which can take these imperfections into account, for instance by 
using 3D acquisitions with full limb coverage which allows accurate offline matching 
of datasets in a standardized way. 
7.3 Multi-parametric MRI in DMD: Insight in the pathophysiology 
and the value of MR outcome measures to monitor tissue changes
Quantitative MRI and MRS are important non-invasive methods to follow disease 
progression in DMD and are considered as promising surrogate outcome measures 
for clinical trials. 10 So far the main focus of the field has been on individual 
quantitative imaging techniques with the ability to reflect variations in the extent 
of fat replacement, inflammation, and metabolic changes; and to correlate these 
with disease progression, age and function. In addition, it is known and has been 
investigated extensively with qMRI, that muscles become affected at different time 
points and at different rates.11-14 However, both the origin of this variation in disease 
progression and the pathogenic mechanism behind this degeneration is not fully 
clear. 15, 16 To date, only little is known about the relationship between the various 
pathophysiological processes and if/how those pathophysiological processes 
vary within individual muscles. Such knowledge could contribute to a better 
understanding of the underlying pathophysiology and to potential strategies aimed 
at preserving muscle tissue. 
7.3.1 Variations within individual muscles
Chapter three of this thesis focused on variations in muscle degeneration within 
individual muscles and showed that muscle fat replacement was non-uniformly 
distributed along the proximodistal muscle axis in DMD, with higher fat fractions 
in the end-regions compared to the muscle belly. The detection of this specific 
degeneration pattern, combined with the non-uniform mechanical strain distribution 
along the proximodistal muscle axis in healthy muscle tissue, higher expression 
levels of dystrophin in the muscle end-regions and the susceptibility of dystrophin-
deficient muscle to stress-induced injury, all point towards mechanical disruption 
of the sarcolemma as one of the key factors for muscle degeneration in DMD.17-
21 However, the specific role of the mechanical component in the degeneration 
process needs to be investigated in further detail. This knowledge could for 
example contribute to explaining the specific pattern of muscle involvement in 
DMD. Closely-related factors such as fiber-type composition and the amount of 
eccentric muscle contractions have already been associated with this specific 
pattern of muscle involvement. 22, 23 Future research could also include evaluation 
131
Summary and general discussion
7
of the stress and strain distributions within individual dystrophic muscle fibers, as 
well as evaluation of the change in these distributions when muscle degeneration 
progresses. Ultimately, it would be relevant to evaluate how this specific knowledge 
could contribute to potential strategies aimed at preserving muscle tissue and how 
it relates to functional measures.  
The difference in parabolic curvature between low, intermediate and highly affected 
muscles, with a more prominent curvature in the intermediately affected muscles, 
suggests that at least at the start and at the end of the fat transformation process, 
the progression of the parabolic distribution cannot be homogeneous over time. It 
can be questioned how this progression will evolve in the intermediate stages of 
muscle deterioration. A recent study in the arm muscles of DMD patients suggested 
that muscle fat transformation evolved over time with similar rates along the 
proximodistal muscle axis. 24 All these findings together suggest that the muscle 
end-regions seem primarily affected but do not necessarily evolve more rapidly 
over time. However, a more detailed and specific analysis will be needed to further 
evaluate this degeneration process over time.
Furthermore, it would be highly interesting to evaluate whether the other 
pathophysiological processes, such as muscle inflammation and metabolic 
alterations, show the same parabolic distribution along the proximodistal muscle 
axis. Based on the notion that metabolic alterations and inflammation-like processes 
occur prior to more structural changes, and considering that muscle tissue is known 
to be progressively replaced with fat in DMD, it is likely that this specific distribution 
may only be visible in the early disease phases. As such, it could be that in order to 
be able to visualize this, DMD patients below the age of five have to be recruited. 
Acquisition of MR data sets in such a young population might not be practically 
feasible without sedation. In addition, this is one of the reasons, why scanning of 
such a young study population is not allowed by most medical ethical committees. 
Alternatively, it is also likely that none of the other pathophysiological changes 
shows a similar parabolic distribution, as the specific shape of the distribution 
largely depends on the progressive nature of muscle fat replacement with its well 
defined begin and end stage. 
7.3.2 The inter relation between these pathophysiological processes. 
Muscles of DMD patients are characterized by a wide variety of histological changes 
such as inflammation, changes in resting energy metabolism and fat infiltration. 25 
However, so far, the exact time course and relation between these pathophysiological 
changes is not fully understood. In chapter 4 of this thesis we showed that that it 
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is possible to distinguish between early and late pathophysiological processes in 
individual muscles. PDE-levels and water T2 relaxation times were elevated prior 
to the occurrence of structural changes, and remained elevated in later disease 
stages. In contrast, the other metabolic indices (Pi/PCr and intracellular tissue pH) 
showed alterations simultaneously with the replacement of muscle tissue by fat or 
did not change at all (Pi/ATP and PCr/ATP). These findings are partly in line with 
previous work which reported elevated water T2 relaxation times in muscles with low 
fat levels. 26, 27 Knowledge about this time relation is useful to define a time frame 
in which the trajectory of individual pathophysiological processes can be assessed 
in more detail. In addition, our work and that of others also showed that analysis 
of all these individual pathophysiological processes, reflecting multiple aspects of 
muscle damage, provides a much more comprehensive view of the disease state of 
a specific muscle. 28 
The trajectories of these metabolic indices and fat fraction have been investigated 
in more detail over a two-year time period in chapter 5. We found that none of 
the metabolic indices differed between the consecutive time points (Baseline, 
12-months and 24-months) while muscle fat fraction did increase with time. These 
findings suggest that the metabolic alterations are not directly associated with the 
severity of muscle damage in DMD. However, the absence of this relationship may 
be confounded by the fact that there are both early and late metabolic alterations, 
as discussed before in chapter 4. This notion is supported by work in the arm muscles 
of ambulant and non-ambulant DMD patients, and by most previous cross-sectional 
work in older DMD boys/men not on steroid treatment. 29-34 These findings suggest 
that detecting a relation between metabolic alterations and disease progression 
is highly dependent on the disease stage in relation to the outcome parameter. 
Thereby it is highly likely that the relation with disease progression varies between 
disease phases. A longer follow-up in younger and older DMD patients should be 
performed to investigate the trajectories of these early and late pathophysiological 
processes in more detail. The wide range of muscle involvement in a specific patient 
together with the large variation in pathophysiological changes along the course 
of the disease, stress the importance of muscle specific measurements while 
conducting such investigations. However, it is important to consider that, while 
muscle-specific analyses are much more sensitive, these type of measurements are 
not always feasible in practice, due to hardware accessibility and time constraints. 
From a clinical point of view, it would be interesting to find out if some of the early 
pathophysiological changes have the ability to predict the course of some of the later 
pathophysiological changes, and ideally to relate those changes to loss of functional 
ability. Past studies have shown that muscle fat fraction of a single muscle or a group 
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of muscles, detected with DIXON imaging, has the ability to predict loss of functional 
abilities. 35, 36 Therefore, it could be that a combination of pathophysiological changes, 
as it creates a more complete view of the clinical state of a patient, in one muscle or 
a group of muscles, is more sensitive to predict loss of certain functional abilities or 
specific function milestones. Ultimately, the ability to differentiate between slow- 
and fast-progressing patients based on a combination of MR measurements in one 
or multiple muscles, would be valuable for disease-monitoring purposes but also for 
identifying selection criteria for therapeutic interventions. For such analysis, large 
patient cohorts that cross broad age ranges are required and need to be followed for 
a much longer time period. 
Despite the fact that all findings in this thesis point towards using multi-parametric 
MRI to advance the understanding of the pathophysiology, it is also important 
to note that more detailed analysis of individual techniques/processes are still 
required. For instance, acquisition of high SNR spatially-resolved 31P MRS data sets 
allows one to distinguish between glycerol 3-phosphocholine (GPC) and glycerol 
3-phosphoethanolamine (GPE) in PDE, and as such allows the assessment of the 
origin of the elevation in PDE-levels, which contributes to a better understanding of 
the pathophysiology. Alternatively, other so far not yet implemented MR techniques 
need to be explored as they could be of value as outcome parameters. Such 
techniques include for example 23Na MRI to assess inflammation, T1 rho mapping 
aimed at measuring fibrosis, Arterial Spin Labelling (ASL) to assess tissue perfusion 
and MR Elastography to detect differences in tissue stiffness. Subsequently, more 
dynamic measurements such as the recovery of PCr and blood flow after sub-
maximal exercise or the change of fiber length and pennation angle due to motion, 
may provide insight into factors that play a role in daily life activities.
7.3.3 Potential MR outcome parameter
With the expansion of therapeutical developments in DMD 37-40, numerous studies 
have focused on mapping of the natural disease progression of DMD with qMRI. Until 
now, muscle fat fraction and water T2 measurements seem to be the most promising 
MR outcome parameters in DMD.28, 41 However, since therapeutic developments at 
the moment aim at preserving or improving muscle tissue, an early marker with a 
high discriminative ability to detect changes in muscle tissue will be essential. Both 
water T2 and %fat do not fulfill these criteria. 
36, 42-44 
This thesis shows that PDE-levels detected with 31P MRS could reflect muscle tissue 
changes with a high discriminative ability (there was a two-fold increase in patients 
compared to controls) in both the early and more advanced disease stages. Despite 
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the fact that the exact origin of the elevated PDE-levels in DMD is not fully clear, 
these changes in muscle tissue could have value as outcome parameter. However, 
several issues need to be investigated in more detail in order to explore this. To start 
with, it would be crucial to find out if in DMD patients PDE-levels detected with 31P 
MRS are able to revert back to normal values upon therapy, as previously shown in 
Golden Retriever Muscular Dystrophy dogs by using adeno-associated virus (AVV) 
vector therapy. 45 At the moment, the only therapy available for DMD patients are 
corticosteroids which slows the pace of the disease progression, probably as a result 
of reducing the inflammatory component. 46 Although it is unclear what the effect 
of corticosteroids will be on metabolic pathways, it could be interesting to test the 
short- and long-term effects of corticosteroids on several MR outcome parameters. 
Subsequently, the full trajectory of PDE-levels along the course of the disease 
should be assessed, as it is highly valuable to know the natural progression of 
change, to relate potential therapeutic effects to. Lastly, it is also of interest to know 
how accurate and reproducible PDE-levels can be detected between measurements 
within a single imaging center but also across centers. Previous studies assessed 
the reproducibility of %fat and water T2 measurements in both HC subjects and 
DMD patients within and between centers and found CV values ranging between 
0.8-8%.47 The CV values found for quantifying PDE-levels in this work, for high and 
lower SNR conditions, are similar to these values,  and below the general acceptable 
level of agreement (<10%). This suggests that even in more highly affected patients 
(simulated by the lower SNR data-sets) one can accurately quantify PDE-levels 
within a center. In other words, this means that PDE-levels could be used to monitor 
muscle tissue changes across different stages of the disease. For future clinical 
studies, it is recommended to establish a standardized protocol which can be used 
to determine the reproducibility of quantifying PDE-levels with spatially-resolved 
measurements across centers. 
The two-fold elevation of PDE-levels compared to controls, its detection prior to 
structural changes, and its high reproducibility confirm the value of PDE-levels as 
an MR outcome parameter to monitor muscle tissue changes.  However, it can be 
questioned how feasible the use of spatially resolved 31P MRS is to detect PDE-
levels in clinical trials. To date, most hospitals have only clinical MR systems and 
surface coils at their disposal, which do not allow such advanced measurements. 
In practice, this will most likely result in surface coil localized measurements, 
which generate a weighted value from multiple muscles at once and might not 
be sensitive enough to detect subtle changes in individual muscles. With respect 
to therapy developments in DMD, so far it is uncertain if and to what extent there 
will be changes in the muscle with appropriate therapy. At the same time it is 
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unclear where these potential therapeutic effects will be manifested. Due to this 
lack of knowledge, it is too early to choose one single MR measure as an outcome 
parameter. Therefore it is highly recommended to use a multi-parametric approach 
in which the assessment of metabolic alterations, PDE-levels specifically, and a 
variety of other pathophysiological processes are embedded. 
7.4 Future perspectives: Acceleration
This thesis provides evidence, from both a pathophysiological and methodological 
perspective, that it is important to use multi-parametric MRI in skeletal muscle 
disease. The feasibility of reaching that goal depends on finding an appropriate 
balance between scan duration and the necessary quality of the data. Acceleration of 
scan sequences can provide freedom in either increasing variety or quality. Chapter 
6 of this thesis showed that implementation of a fast B1
+ shimming technique, as 
applied to  a whole-body fat-water separation approach, improved data quality 
without loss of essential scan time. These mapping approaches do not have any 
direct diagnostic value but do directly influence data quality. Over the past decade, 
other approaches aimed at acceleration of diagnostic scans, such as parallel imaging, 
compressed sensing, interleaving and integrating of sequences, have emerged. 
Acceleration factors of 2-5 fold have been achieved with these various methods 
without loss of data quality in skeletal muscle applications. 48-50 These acceleration 
factors can be highly beneficial for the implementation of multi-parametric MRI, 
but also in exercise challenges, in which blood flow and energy metabolism very 
quickly return to resting state settings, and in whole body applications. Although the 
foundations for speeding up of acquisitions are available, they will need to be further 
developed to become clinically applicable. 
7.5 Conclusions
This thesis showed the impact of data quality and imperfections in spatial localization 
on the quantification of MR outcome parameters, but more importantly, emphasized 
the essence of high quality multi-parametric MRI in order to be able to ascribe tissue 
changes to either pathology or confounding factors in skeletal muscle applications. 
More specifically, this thesis showed that sufficient levels of SNR resulted in a robust 
estimation of MR outcome parameters, and that MR protocols need to be optimized 
accordingly. Subsequently, confounding factors need to be measured and accounted 
for, in order to have truly quantitative measures that reflect pathology-related changes. 
In addition, this thesis showed how different MR measures can be depicted in a 
complementary way to describe pathophysiological processes during the course of 
the disease. The use of muscle-specific measurements and multi-parametric MRI both 
contributed to a better understanding of the disease-related changes in DMD. In the 
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future, multi-parametric MRI and new technical developments should complement 
each other in an effort to advance the understanding of the pathophysiology and 
to determine the value of MR outcome measures to assess muscle tissue changes. 
At the same time, it is important to link this comprehensive MR muscle profile to 
muscle function, functional abilities and functional milestones.
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In dit proefschrift zijn verschillende kwantitatieve MRI technieken gecombineerd 
en vergeleken  tussen patiënten met Duchenne spierdystrofie (DMD) en gezonde 
controle deelnemers. Dit is zowel op cross-sectionele als longitudinale data gedaan. 
Het doel hiervan was om de onderliggende pathofysiologie beter te begrijpen. 
Daarnaast keken we of deze kwantitatieve MRI parameters potentie hebben om 
veranderingen in spierweefsel te meten in een klinische setting. Tenslotte hebben 
we gekeken naar het effect van data-kwaliteit, meet nauwkeurigheid in longitudinale 
metingen en verstorende factoren op kwantificatie van deze MR parameters. 
In hoofdstuk 2 hebben we het effect van vetfractie, Signaal-Ruis-Ratio (SNR) en 
T2 relaxatie tijd op DTI metingen in skeletspieren van patiënten met DMD in kaart 
gebracht. We hebben laten zien dat voldoende SNR essentieel is om een betrouwbare 
schatting van de DTI parameters te kunnen doen. Daarnaast hebben we laten zien 
dat in-vivo metingen van vetfractie en water T2 nodig zijn om te achterhalen of de 
verschillen die we zagen in de DTI parameters komen door de pathofysiologie of 
door andere factoren. Na het corrigeren van de DTI metingen voor SNR, T2 en de 
vetfractie vonden we geen verschillen in DTI parameters tussen patiënten met DMD 
en gezonde controle jongens.  
In hoofdstuk 3 hebben we naar de vetverdeling binnen één spier gekeken, in DMD 
patiënten en gezonde controle deelnemers, met behulp van de Dixon techniek. 
We hebben laten zien dat vetfracties binnen een spier ongelijkmatig verdeeld 
waren langs de proximo-distale spieras, met hogere vetfracties aan de uiteindes 
van de spieren in vergelijking tot de spierbuik. Daarnaast hebben laten zien hoe 
belangrijk het is om op exact dezelfde locatie te meten binnen één spier. Een kleine 
verschuiving (15mm) van de meetlocatie langs de proximo-distale as resulteerde in 
een verschil in vetfractie van  1-2% en kon oplopen tot 12%. Dit kan een enorme 
invloed hebben op het gebruik van kwantitatieve MRI metingen  als potentiele 
uitkomstmaat in klinische trials en benadrukt het belang van nauwkeurigheid in 
herpositionering in longitudinale MRI studies. Daarnaast geven deze resultaten 
aan dat mechanische verstoring van de spiermembraan  één  van de belangrijkere 
factoren in de pathofysiologie van DMD zou zijn.
In hoofdstuk 4 hebben we gebruik gemaakt van verschillende kwantitatieve 
MR technieken om meer inzicht te krijgen in de relatie tussen de verschillende 
pathofysiologische veranderingen die voorkomen in de spieren van DMD patiënten. 




spieren met en zonder vet infiltratie, met zowel imaging als fosfor spectroscopie. 
We hebben gevonden dat PDE niveaus en water T2 waardes al verhoogd waren in 
spieren die nog geen vet infiltratie lieten zien. De ratio van in-organisch fosfaat 
over ATP en intracellulaire weefsel pH waren alleen veranderd in spieren die al vet 
infiltratie lieten zien. Dit betekent dat we in staat zijn om een onderscheid te maken 
tussen vroege en latere pathofysiologische veranderingen in de spieren van DMD 
patiënten. Daarnaast hebben we ook gevonden dat PDE niveaus en water T2 waardes 
verhoogd bleven in spieren die vet-infiltratie lieten zien. Dit impliceert dat PDE 
niveaus en water T2 waardes niet alleen kunnen functioneren als een vroege maat, 
maar misschien  in meer aangedane spieren. De potentie van deze uitkomstmaten 
moet verder onderzocht worden aan de hand van longitudinale studies. 
In hoofdstuk 5 hebben we aan de hand van longitudinale kwantitatieve MR data van 
verschillende onderbeenspieren, het tijdsverloop van veranderingen in PDE niveaus 
en vet infiltratie bekeken.  DMD patiënten en gezonde controles werden drie keer 
gemeten gedurende een periode van 24 maanden met tussenpozen van één jaar. 
PDE niveaus waren twee keer zo hoog in vergelijking tot gezonde controles, in alle 
geanalyseerde spieren op alle tijdspunten met uitzondering van de Tibialis Posterior 
spier tijdens de baseline meting. We vonden  geen verschillen in PDE-niveaus tussen 
de drie tijdspunten. De vetfractie nam significant toe tussen de tijdspunten in de 
meerderheid van de geanalyseerde spieren van de DMD patiënten. Dit suggereert 
dat PDE-niveaus een andere verloop over de tijd laat zien dan de vetfractie. 
Daarnaast hebben we gekeken hoe reproduceerbaar PDE niveaus gemeten kunnen 
worden en wat het effect van SNR is tijdens het kwantificeren van PDE. We lieten 
zien dat PDE niveaus accuraat en reproduceerbaar gemeten kunnen worden met 
fosfor spectroscopie in hoge en lage SNR datasets. Dit betekent dat PDE niveaus 
in vroege en latere fase van ziekte betrouwbaar gemeten kunnen worden. Al 
deze bevindingen samen bevestigen de potentie van PDE niveaus als maat om 
veranderingen in spierweefsel in kaart te brengen in patiënten met DMD. 
In hoofdstuk 6 is de implementatie van een snelle DREAM B1
+ shimming methode 
geëvalueerd als  toepassing voor beeldvorming van het hele lichaam op 3T MRI 
scanner. Beeldvorming van het hele lichaam is een toepassing die erg gevoelig is 
voor ongelijkmatigheden in het excitatie (B1
+) veld. Met behulp van B1
+ shimming 
worden deze ongelijkmatigheden zo klein mogelijk gemaakt. Het gebruik van deze 
nieuwe DREAM B1
+ shimming techniek zorgde voor een significante toename in 
data-kwaliteit van de beelden gemaakt in de bovenbenen en het bovenlichaam. 
Naast deze optische  verbeteringen in data-kwaliteit in deze regio’s vonden we 
ook nauwkeurigere excitatie hoek en een homogener B1




+ mappen. Tenslotte zorgde de nieuwe DREAM methode voor een 
versnelling van een factor van 10 in vergelijking tot de tot dan toe beschikbare B1
+ 
shimming methodes. Dit suggereert dat DREAM B1
+ shimming een veelbelovende 
techniek is die niet alleen gebruikt kan worden voor beeldvorming van het hele 
lichaam maar ook van belang is voor toepassingen in regio’s die gevoelig zijn voor 
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